| Year |
Citation |
Score |
| 2022 |
Stampanoni Bassi M, Iezzi E, Centonze D. Multiple sclerosis: Inflammation, autoimmunity and plasticity. Handbook of Clinical Neurology. 184: 457-470. PMID 35034754 DOI: 10.1016/B978-0-12-819410-2.00024-2 |
0.339 |
|
| 2020 |
Ziccardi L, Barbano L, Boffa L, Albanese M, Grzybowski A, Centonze D, Parisi V. Morphological Outer Retina Findings in Multiple Sclerosis Patients With or Without Optic Neuritis. Frontiers in Neurology. 11: 858. PMID 33041959 DOI: 10.3389/Fneur.2020.00858 |
0.351 |
|
| 2020 |
Stampanoni Bassi M, Buttari F, Gilio L, De Paolis N, Fresegna D, Centonze D, Iezzi E. Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective. Frontiers in Neurology. 11: 566. PMID 32733354 DOI: 10.3389/Fneur.2020.00566 |
0.428 |
|
| 2020 |
Chisari CG, Solaro C, Annunziata P, Bergamaschi R, Bianco A, Bonavita S, Brescia Morra V, Bruno Bossio R, Capello E, Castelli L, Cavalla P, Costantino G, Centonze D, Cottone S, Danni MC, et al. Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32661083 DOI: 10.1136/Jnnp-2019-322480 |
0.326 |
|
| 2020 |
Bruno A, Dolcetti E, Rizzo FR, Fresegna D, Musella A, Gentile A, De Vito F, Caioli S, Guadalupi L, Bullitta S, Vanni V, Balletta S, Sanna K, Buttari F, Stampanoni Bassi M, ... Centonze D, et al. Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis. Frontiers in Cellular Neuroscience. 14: 169. PMID 32655374 DOI: 10.3389/Fncel.2020.00169 |
0.378 |
|
| 2020 |
Stampanoni Bassi M, Iezzi E, Drulovic J, Pekmezovic T, Gilio L, Furlan R, Finardi A, Marfia GA, Sica F, Centonze D, Buttari F. IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis. Frontiers in Cellular Neuroscience. 14: 120. PMID 32655367 DOI: 10.3389/Fncel.2020.00120 |
0.374 |
|
| 2020 |
Sørensen PS, Centonze D, Giovannoni G, Montalban X, Selchen D, Vermersch P, Wiendl H, Yamout B, Salloukh H, Rieckmann P. Expert opinion on the use of cladribine tablets in clinical practice. Therapeutic Advances in Neurological Disorders. 13: 1756286420935019. PMID 32636933 DOI: 10.1177/1756286420935019 |
0.314 |
|
| 2020 |
Farini D, Cesari E, Weatheritt RJ, La Sala G, Naro C, Pagliarini V, Bonvissuto D, Medici V, Guerra M, Di Pietro C, Rizzo FR, Musella A, Carola V, Centonze D, Blencowe BJ, et al. A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum. Cell Reports. 31: 107703. PMID 32492419 DOI: 10.1016/J.Celrep.2020.107703 |
0.325 |
|
| 2020 |
Musella A, Gentile A, Guadalupi L, Rizzo FR, De Vito F, Fresegna D, Bruno A, Dolcetti E, Vanni V, Vitiello L, Bullitta S, Sanna K, Caioli S, Balletta S, Nencini M, ... ... Centonze D, et al. Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis. Cells. 9. PMID 32455907 DOI: 10.3390/Cells9051290 |
0.411 |
|
| 2020 |
Patti F, Chisari CG, D'Amico E, Annovazzi P, Banfi P, Bergamaschi R, Clerici R, Conti MZ, Cortese A, Fantozzi R, Fischetti M, Frigo M, Gatto M, Immovilli P, Leoni S, ... ... Centonze D, et al. Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study). Multiple Sclerosis and Related Disorders. 42: 102124. PMID 32353755 DOI: 10.1016/J.Msard.2020.102124 |
0.371 |
|
| 2020 |
Centonze D, Leocani L, Feys P. Advances in physical rehabilitation of multiple sclerosis. Current Opinion in Neurology. 33: 255-261. PMID 32304436 DOI: 10.1097/Wco.0000000000000816 |
0.344 |
|
| 2020 |
Dalgas U, Hvid LG, Kwakkel G, Motl RW, de Groot V, Feys P, Op't Eijnde B, Coote S, Beckerman H, Pfeifer K, Streber R, Peters S, Riemann-Lorenz K, Rosenkranz SC, Centonze D, et al. Moving exercise research in multiple sclerosis forward (the MoXFo initiative): Developing consensus statements for research. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520910360. PMID 32162578 DOI: 10.1177/1352458520910360 |
0.335 |
|
| 2020 |
Musella A, Fresegna D, Rizzo FR, Gentile A, De Vito F, Caioli S, Guadalupi L, Bruno A, Dolcetti E, Buttari F, Bullitta S, Vanni V, Centonze D, Mandolesi G. 'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting. Expert Opinion On Therapeutic Targets. 1-10. PMID 31899994 DOI: 10.1080/14728222.2020.1709823 |
0.348 |
|
| 2019 |
Stampanoni Bassi M, Iezzi E, Pavone L, Mandolesi G, Musella A, Gentile A, Gilio L, Centonze D, Buttari F. Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity. International Journal of Molecular Sciences. 21. PMID 31878257 DOI: 10.3390/Ijms21010143 |
0.4 |
|
| 2019 |
Stampanoni Bassi M, Buttari F, Maffei P, Paolis N, Sancesario A, Gilio L, Pavone L, Pasqua G, Simonelli I, Sica F, Fantozzi R, Bellantonio P, Centonze D, Iezzi E. Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. PMID 31818686 DOI: 10.1016/J.Clinph.2019.10.023 |
0.381 |
|
| 2019 |
Kooij G, Derada Troletti C, Leuti A, Norris PC, Riley I, Albanese M, Ruggieri S, Libreros S, van der Pol SMA, van Het Hof B, Schell Y, Guerrera G, Buttari F, Mercuri NB, Centonze D, et al. Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction. Haematologica. PMID 31780628 DOI: 10.3324/Haematol.2019.219519 |
0.373 |
|
| 2019 |
Sica F, Centonze D, Buttari F. Fingolimod Immune Effects Beyond Its Sequestration Ability. Neurology and Therapy. 8: 231-240. PMID 31696392 DOI: 10.1007/S40120-019-00162-7 |
0.309 |
|
| 2019 |
Nicoletti CG, Landi D, Monteleone F, Mataluni G, Albanese M, Lauretti B, Rocchi C, Simonelli I, Boffa L, Buttari F, Mercuri NB, Centonze D, Marfia GA. Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis. Cns Drugs. PMID 31650471 DOI: 10.1007/S40263-019-00676-6 |
0.389 |
|
| 2019 |
Gentile A, Musella A, De Vito F, Rizzo FR, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Centonze D, Mandolesi G. Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis. Frontiers in Immunology. 10: 2197. PMID 31572399 DOI: 10.3389/Fimmu.2019.02197 |
0.357 |
|
| 2019 |
Oreja-Guevara C, Potra S, Bauer B, Centonze D, Giambastiani MP, Giovannoni G, Kesselring J, Langdon D, Morrow SA, Nouvet-Gire J, Pontaga M, Rieckmann P, Schippling S, Alexandri N, Shanahan J, et al. Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care. Advances in Therapy. PMID 31487006 DOI: 10.1007/S12325-019-01071-9 |
0.316 |
|
| 2019 |
Restivo DA, Alfonsi E, Casabona A, Hamdy S, Tassorelli C, Panebianco M, Marchese-Ragona R, Quartarone A, Centonze D, Pavone A, Bassi MS. Corrigendum to 'A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis' [Clin. Neurophysiol. 130 (2019) 1017-1024]. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 130: 2013. PMID 31473144 DOI: 10.1016/J.Clinph.2019.08.004 |
0.306 |
|
| 2019 |
Leocani L, Chieffo R, Gentile A, Centonze D. Beyond rehabilitation in MS: Insights from non-invasive brain stimulation. Multiple Sclerosis (Houndmills, Basingstoke, England). 25: 1363-1371. PMID 31469356 DOI: 10.1177/1352458519865734 |
0.369 |
|
| 2019 |
Colamatteo A, Maggioli E, Azevedo Loiola R, Hamid Sheikh M, Calì G, Bruzzese D, Maniscalco GT, Centonze D, Buttari F, Lanzillo R, Perna F, Zuccarelli B, Mottola M, Cassano S, Galgani M, et al. Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients. Journal of Immunology (Baltimore, Md. : 1950). PMID 31462505 DOI: 10.4049/Jimmunol.1801683 |
0.372 |
|
| 2019 |
Stampanoni Bassi M, Iezzi E, Mori F, Simonelli I, Gilio L, Buttari F, Sica F, De Paolis N, Mandolesi G, Musella A, De Vito F, Dolcetti E, Bruno A, Furlan R, Finardi A, ... ... Centonze D, et al. Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis. Neurorehabilitation and Neural Repair. 1545968319868713. PMID 31431121 DOI: 10.1177/1545968319868713 |
0.411 |
|
| 2019 |
Grimaldi AE, De Giglio L, Haggiag S, Bianco A, Cortese A, Crisafulli SG, Monteleone F, Marfia G, Prosperini L, Galgani S, Mirabella M, Centonze D, Pozzilli C, Castelli L. The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray). Plos One. 14: e0219670. PMID 31361750 DOI: 10.1371/Journal.Pone.0219670 |
0.363 |
|
| 2019 |
Ciccocioppo F, Lanuti P, Pierdomenico L, Simeone P, Bologna G, Ercolino E, Buttari F, Fantozzi R, Thomas A, Onofrj M, Centonze D, Miscia S, Marchisio M. The Characterization of Regulatory T-Cell Profiles in Alzheimer's Disease and Multiple Sclerosis. Scientific Reports. 9: 8788. PMID 31217537 DOI: 10.1038/S41598-019-45433-3 |
0.31 |
|
| 2019 |
Capone A, Bianco M, Ruocco G, De Bardi M, Battistini L, Ruggieri S, Gasperini C, Centonze D, Sette C, Volpe E. Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients. Cells. 8. PMID 31167379 DOI: 10.3390/Cells8060533 |
0.363 |
|
| 2019 |
Stampanoni Bassi M, Iezzi E, Buttari F, Gilio L, Simonelli I, Carbone F, Micillo T, De Rosa V, Sica F, Furlan R, Finardi A, Fantozzi R, Storto M, Bellantonio P, Pirollo P, ... ... Centonze D, et al. Obesity worsens central inflammation and disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519853473. PMID 31161863 DOI: 10.1177/1352458519853473 |
0.347 |
|
| 2019 |
Ciccocioppo F, Lanuti P, Centonze D, Miscia S, Marchisio M. The Link Among Neurological Diseases: Extracellular Vesicles as a Possible Brain Injury Footprint. Neuro-Signals. 27: 25-39. PMID 31150575 DOI: 10.33594/000000116 |
0.323 |
|
| 2019 |
Gambardella S, Limanaqi F, Ferese R, Biagioni F, Campopiano R, Centonze D, Fornai F. ccf-mtDNA as a Potential Link Between the Brain and Immune System in Neuro-Immunological Disorders. Frontiers in Immunology. 10: 1064. PMID 31143191 DOI: 10.3389/Fimmu.2019.01064 |
0.319 |
|
| 2019 |
Gentile A, De Vito F, Fresegna D, Rizzo FR, Bullitta S, Guadalupi L, Vanni V, Buttari F, Stampanoni Bassi M, Leuti A, Chiurchiù V, Marfia GA, Mandolesi G, Centonze D, Musella A. Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons. Neuropathology and Applied Neurobiology. PMID 31125471 DOI: 10.1111/Nan.12569 |
0.411 |
|
| 2019 |
Mandolesi G, Bullitta S, Fresegna D, De Vito F, Rizzo FR, Musella A, Guadalupi L, Vanni V, Stampanoni Bassi M, Buttari F, Viscomi MT, Centonze D, Gentile A. Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination. Neurobiology of Disease. 129: 102-117. PMID 31100354 DOI: 10.1016/J.Nbd.2019.05.010 |
0.356 |
|
| 2019 |
Restivo DA, Alfonsi E, Casabona A, Hamdy S, Tassorelli C, Panebianco M, Marchese-Ragona R, Quartarone A, Centonze D, Pavone A, Stampanoni Bassi M. A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 130: 1017-1024. PMID 31009904 DOI: 10.1016/J.Clinph.2019.04.003 |
0.338 |
|
| 2019 |
Stampanoni Bassi M, Gentile A, Iezzi E, Zagaglia S, Musella A, Simonelli I, Gilio L, Furlan R, Finardi A, Marfia GA, Guadalupi L, Bullitta S, Mandolesi G, Centonze D, Buttari F. Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis. Frontiers in Neurology. 10: 30. PMID 30761069 DOI: 10.3389/Fneur.2019.00030 |
0.392 |
|
| 2019 |
Nicoletti CG, Monteleone F, Marfia GA, Usiello A, Buttari F, Centonze D, Mori F. Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519828294. PMID 30730244 DOI: 10.1177/1352458519828294 |
0.425 |
|
| 2019 |
Vigo T, La Rocca C, Faicchia D, Procaccini C, Ruggieri M, Salvetti M, Centonze D, Matarese G, Uccelli A. IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism. Cell Death & Disease. 10: 85. PMID 30692524 DOI: 10.1038/S41419-019-1336-4 |
0.352 |
|
| 2019 |
Ruggieri S, Ianniello A, Giglio LD, Altieri M, Centonze D, Copetti M, Cortese A, Fantozzi R, Galgani S, Gasperini C, Grimaldi L, Landi D, Marfia GA, Mirabella M, Nistri R, et al. Different regimen of natalizumab treatment in multiple sclerosis patients: A real world study in Italy Journal of the Neurological Sciences. 405: 338-339. DOI: 10.1016/J.Jns.2019.10.1467 |
0.318 |
|
| 2018 |
Papetti L, Figà Talamanca L, Spalice A, Vigevano F, Centonze D, Valeriani M. Predictors of Evolution Into Multiple Sclerosis After a First Acute Demyelinating Syndrome in Children and Adolescents. Frontiers in Neurology. 9: 1156. PMID 30697184 DOI: 10.3389/Fneur.2018.01156 |
0.349 |
|
| 2018 |
Russo C, Riccio E, Pontillo G, Cocozza S, Tedeschi E, Centonze D, Pisani A. Multiple sclerosis and fabry Disease, two sides of the coin? The case of an Italian family. Multiple Sclerosis and Related Disorders. 26: 164-167. PMID 30268036 DOI: 10.1016/J.Msard.2018.09.019 |
0.348 |
|
| 2018 |
Pieri M, Zenobi R, Morello M, Storto M, Buttari F, Centonze D, Bernardini S, Dessi M. Multiple Sclerosis: kFLC index values related to gender. Multiple Sclerosis and Related Disorders. 26: 58-60. PMID 30223231 DOI: 10.1016/J.Msard.2018.08.018 |
0.388 |
|
| 2018 |
Stampanoni Bassi M, Iezzi E, Landi D, Monteleone F, Gilio L, Simonelli I, Musella A, Mandolesi G, De Vito F, Furlan R, Finardi A, Marfia GA, Centonze D, Buttari F. Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course. Journal of Neurology. PMID 30167879 DOI: 10.1007/S00415-018-8994-5 |
0.375 |
|
| 2018 |
Musella A, Gentile A, Rizzo FR, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Centonze D, Mandolesi G. Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions. Frontiers in Aging Neuroscience. 10: 238. PMID 30135651 DOI: 10.3389/Fnagi.2018.00238 |
0.381 |
|
| 2018 |
Landi D, Ragonese P, Prosperini L, Nociti V, Haggiag S, Cortese A, Fantozzi R, Pontecorvo S, Ferraro E, Buscarinu MC, Mataluni G, Monteleone F, Salvetti M, Di Battista G, Francia A, ... ... Centonze D, et al. Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29970387 DOI: 10.1136/Jnnp-2018-318468 |
0.326 |
|
| 2018 |
Prosperini L, Lucchini M, Haggiag S, Bellantonio P, Bianco A, Buscarinu MC, Buttari F, Centonze D, Cortese A, De Giglio L, Fantozzi R, Ferraro E, Fornasiero A, Francia A, Galgani S, et al. Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study. Neurology. PMID 29875218 DOI: 10.1212/Wnl.0000000000005772 |
0.382 |
|
| 2018 |
Rizzo FR, Musella A, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Mandolesi G, Centonze D, Gentile A. Tumor Necrosis Factor and Interleukin-1 Modulate Synaptic Plasticity during Neuroinflammation. Neural Plasticity. 2018: 8430123. PMID 29861718 DOI: 10.1155/2018/8430123 |
0.402 |
|
| 2018 |
Stampanoni Bassi M, Iezzi E, Marfia GA, Simonelli I, Musella A, Mandolesi G, Fresegna D, Pasqualetti P, Furlan R, Finardi A, Mataluni G, Landi D, Gilio L, Centonze D, Buttari F. Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis. Journal of Neuroinflammation. 15: 108. PMID 29655371 DOI: 10.1186/S12974-018-1150-4 |
0.4 |
|
| 2018 |
Mango D, Nisticò R, Furlan R, Finardi A, Centonze D, Mori F. PDGF Modulates Synaptic Excitability and Short-Latency Afferent Inhibition in Multiple Sclerosis. Neurochemical Research. PMID 29392518 DOI: 10.1007/S11064-018-2484-0 |
0.43 |
|
| 2018 |
Gentile A, Musella A, De Vito F, Fresegna D, Bullitta S, Rizzo FR, Centonze D, Mandolesi G. Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake. Journal of Neuroinflammation. 15: 5. PMID 29304807 DOI: 10.1186/S12974-017-1048-6 |
0.397 |
|
| 2017 |
Stampanoni Bassi M, Gilio L, Buttari F, Maffei P, Marfia GA, Restivo DA, Centonze D, Iezzi E. Remodeling Functional Connectivity in Multiple Sclerosis: A Challenging Therapeutic Approach. Frontiers in Neuroscience. 11: 710. PMID 29321723 DOI: 10.3389/Fnins.2017.00710 |
0.406 |
|
| 2017 |
Rieckmann P, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Kesselring J, Kobelt G, Langdon D, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P, et al. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group. Multiple Sclerosis and Related Disorders. 19: 153-160. PMID 29241142 DOI: 10.1016/J.Msard.2017.11.013 |
0.358 |
|
| 2017 |
Stampanoni Bassi M, Garofalo S, Marfia GA, Gilio L, Simonelli I, Finardi A, Furlan R, Sancesario GM, Di Giandomenico J, Storto M, Mori F, Centonze D, Iezzi E. Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis. Frontiers in Molecular Neuroscience. 10: 390. PMID 29209169 DOI: 10.3389/Fnmol.2017.00390 |
0.389 |
|
| 2017 |
Monteleone F, Nicoletti CG, Stampanoni Bassi M, Iezzi E, Buttari F, Furlan R, Finardi A, Marfia GA, Centonze D, Mori F. Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain. Journal of Neuroimmunology. PMID 29174194 DOI: 10.1016/J.Jneuroim.2017.11.012 |
0.364 |
|
| 2017 |
La Rocca C, Carbone F, De Rosa V, Colamatteo A, Galgani M, Perna F, Lanzillo R, Brescia Morra V, Orefice G, Cerillo I, Florio C, Maniscalco GT, Salvetti M, Centonze D, Uccelli A, et al. Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration. Metabolism: Clinical and Experimental. 77: 39-46. PMID 29132538 DOI: 10.1016/J.Metabol.2017.08.011 |
0.355 |
|
| 2017 |
Chiurchiù V, van der Stelt M, Centonze D, Maccarrone M. The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases. Progress in Neurobiology. PMID 29097192 DOI: 10.1016/J.Pneurobio.2017.10.007 |
0.356 |
|
| 2017 |
Ottonello M, Pellicciari L, Centonze D, Foti C, Pistarini C, Albensi C, Giordano A. The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis. Disability and Rehabilitation. 1-7. PMID 29069950 DOI: 10.1080/09638288.2017.1393699 |
0.305 |
|
| 2017 |
Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M. Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study). Journal of Neurology. PMID 29063244 DOI: 10.1007/S00415-017-8642-5 |
0.31 |
|
| 2017 |
Rossi S, Studer V, Motta C, Polidoro S, Perugini J, Macchiarulo G, Giovannetti AM, Pareja-Gutierrez L, Calò A, Colonna I, Furlan R, Martino G, Centonze D. Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis. Neurology. PMID 28842450 DOI: 10.1212/Wnl.0000000000004411 |
0.341 |
|
| 2017 |
Colais P, Agabiti N, Davoli M, Buttari F, Centonze D, De Fino C, Di Folco M, Filippini G, Francia A, Galgani S, Gasperini C, Giuliani M, Mirabella M, Nociti V, Pozzilli C, et al. Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy. Neuroepidemiology. 48: 171-178. PMID 28793295 DOI: 10.1159/000479515 |
0.373 |
|
| 2017 |
Musella A, Fresegna D, Rizzo FR, Gentile A, Bullitta S, De Vito F, Guadalupi L, Centonze D, Mandolesi G. A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum. Scientific Reports. 7: 7363. PMID 28779174 DOI: 10.1038/S41598-017-07519-8 |
0.366 |
|
| 2017 |
Messina S, Solaro C, Righini I, Bergamaschi R, Bonavita S, Bossio RB, Brescia Morra V, Costantino G, Cavalla P, Centonze D, Comi G, Cottone S, Danni MC, Francia A, Gajofatto A, et al. Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study). Plos One. 12: e0180651. PMID 28763462 DOI: 10.1371/Journal.Pone.0180651 |
0.323 |
|
| 2017 |
Mandolesi G, Bullitta S, Fresegna D, Gentile A, De Vito F, Dolcetti E, Rizzo FR, Strimpakos G, Centonze D, Musella A. Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum. Neurobiology of Disease. PMID 28757328 DOI: 10.1016/J.Nbd.2017.07.019 |
0.386 |
|
| 2017 |
Stampanoni Bassi M, Leocani L, Comi G, Iezzi E, Centonze D. Can pharmacological manipulation of LTP favor the effects of motor rehabilitation in multiple sclerosis? Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517721358. PMID 28735565 DOI: 10.1177/1352458517721358 |
0.413 |
|
| 2017 |
Landi D, Albanese M, Buttari F, Monteleone F, Boffa L, Rossi S, Motta C, Puma E, Centonze D. Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study. Plos One. 12: e0165415. PMID 28686675 DOI: 10.1371/Journal.Pone.0165415 |
0.327 |
|
| 2017 |
Pieri M, Storto M, Pignalosa S, Zenobi R, Buttari F, Bernardini S, Centonze D, Dessi M. KFLC Index utility in multiple sclerosis diagnosis: Further confirmation. Journal of Neuroimmunology. 309: 31-33. PMID 28601282 DOI: 10.1016/J.Jneuroim.2017.05.007 |
0.323 |
|
| 2017 |
Stampanoni Bassi M, Mori F, Buttari F, Marfia GA, Sancesario A, Centonze D, Iezzi E. Neurophysiology of synaptic functioning in multiple sclerosis. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 128: 1148-1157. PMID 28511127 DOI: 10.1016/J.Clinph.2017.04.006 |
0.455 |
|
| 2017 |
Maccarrone M, Maldonado R, Casas M, Henze T, Centonze D. Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? Expert Review of Clinical Pharmacology. 1-13. PMID 28276775 DOI: 10.1080/17512433.2017.1292849 |
0.335 |
|
| 2017 |
Landi D, De Rossi N, Zagaglia S, Scarpazza C, Prosperini L, Albanese M, Buttari F, Mori F, Marfia GA, Sormani MP, Capra R, Centonze D. No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML. Neurology. PMID 28228569 DOI: 10.1212/Wnl.0000000000003740 |
0.352 |
|
| 2017 |
Gallo P, Centonze D, Marrosu MG. Alemtuzumab for multiple sclerosis: the new concept of immunomodulation Multiple Sclerosis and Demyelinating Disorders. 2. DOI: 10.1186/S40893-017-0024-4 |
0.339 |
|
| 2016 |
Mandolesi G, De Vito F, Musella A, Gentile A, Bullitta S, Fresegna D, Sepman H, Di Sanza C, Haji N, Mori F, Buttari F, Perlas E, Teresa Ciotti M, Hornstein E, Bozzoni I, ... ... Centonze D, et al. miR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27920149 DOI: 10.1523/Jneurosci.0851-16.2017 |
0.341 |
|
| 2016 |
Chiurchiù V, Leuti A, Cencioni MT, Albanese M, De Bardi M, Bisogno T, Centonze D, Battistini L, Maccarrone M. Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors. Pharmacological Research. PMID 27616551 DOI: 10.1016/J.Phrs.2016.09.003 |
0.385 |
|
| 2016 |
Gentile A, Fresegna D, Musella A, Sepman H, Bullitta S, De Vito F, Fantozzi R, Usiello A, Maccarrone M, Mercuri NB, Lutz B, Mandolesi G, Centonze D. Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 13: 231. PMID 27589957 DOI: 10.1186/S12974-016-0682-8 |
0.375 |
|
| 2016 |
Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, Schubart A, Mandolesi G, Centonze D. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis. Journal of Neuroinflammation. 13: 207. PMID 27566665 DOI: 10.1186/S12974-016-0686-4 |
0.449 |
|
| 2016 |
Feys P, Giovannoni G, Dijsselbloem N, Centonze D, Eelen P, Lykke Andersen S. The importance of a multi-disciplinary perspective and patient activation programmes in MS management. Multiple Sclerosis (Houndmills, Basingstoke, England). 22: 34-46. PMID 27465614 DOI: 10.1177/1352458516650741 |
0.358 |
|
| 2016 |
Patti F, Messina S, Solaro C, Amato MP, Bergamaschi R, Bonavita S, Bruno Bossio R, Brescia Morra V, Costantino GF, Cavalla P, Centonze D, Comi G, Cottone S, Danni M, Francia A, et al. Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27160523 DOI: 10.1136/Jnnp-2015-312591 |
0.355 |
|
| 2016 |
Catanzaro G, Pucci M, Viscomi MT, Lanuti M, Feole M, Angeletti S, Grasselli G, Mandolesi G, Bari M, Centonze D, D'Addario C, Maccarrone M. Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis. Journal of Neuroimmunology. 294: 32-40. PMID 27138096 DOI: 10.1016/J.Jneuroim.2016.03.009 |
0.574 |
|
| 2016 |
Albanese M, Zagaglia S, Landi D, Boffa L, Nicoletti CG, Marciani MG, Mandolesi G, Marfia GA, Buttari F, Mori F, Centonze D. Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression. Journal of Neuroinflammation. 13: 36. PMID 26863878 DOI: 10.1186/S12974-016-0502-1 |
0.346 |
|
| 2016 |
Motta C, Palermo E, Studer V, Germanotta M, Germani G, Centonze D, Cappa P, Rossi S, Rossi S. Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis. Plos One. 11: e0148997. PMID 26863109 DOI: 10.1371/Journal.Pone.0148997 |
0.306 |
|
| 2016 |
Mori F, Nisticò R, Nicoletti CG, Zagaglia S, Mandolesi G, Piccinin S, Martino G, Finardi A, Rossini PM, Marfia GA, Furlan R, Centonze D. RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26733422 DOI: 10.1177/1352458515621796 |
0.441 |
|
| 2016 |
Comi G, Amato MP, Bertolotto A, Centonze D, De Stefano N, Farina C, Gallo P, Ghezzi A, Grimaldi LM, Mancardi G, Marrosu MG, Montanari E, Patti F, Pozzilli C, Provinciali L, et al. The heritage of glatiramer acetate and its use in multiple sclerosis Multiple Sclerosis and Demyelinating Disorders. 1. DOI: 10.1186/S40893-016-0010-2 |
0.359 |
|
| 2015 |
Ghezzi A, Mutta E, Bianchi F, Bonavita S, Buttari F, Caramma A, Cavarretta R, Centonze D, Coghe GC, Coniglio G, Del Carro U, Ferrò MT, Marrosu MG, Patti F, Rovaris M, et al. Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 26613723 DOI: 10.1007/S10072-015-2415-7 |
0.333 |
|
| 2015 |
Mandolesi G, Gentile A, Musella A, Fresegna D, De Vito F, Bullitta S, Sepman H, Marfia GA, Centonze D. Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis. Nature Reviews. Neurology. PMID 26585978 DOI: 10.1038/Nrneurol.2015.222 |
0.427 |
|
| 2015 |
Gentile A, De Vito F, Fresegna D, Musella A, Buttari F, Bullitta S, Mandolesi G, Centonze D. Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis. Frontiers in Cellular Neuroscience. 9: 243. PMID 26161070 DOI: 10.3389/Fncel.2015.00243 |
0.395 |
|
| 2015 |
Di Mitri D, Sambucci M, Loiarro M, De Bardi M, Volpe E, Cencioni MT, Gasperini C, Centonze D, Sette C, Akbar AN, Borsellino G, Battistini L. The p38 mitogen-activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis. Immunology. 146: 251-63. PMID 26095162 DOI: 10.1111/Imm.12497 |
0.344 |
|
| 2015 |
Rieckmann P, Boyko A, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Hommes O, Kesselring J, Kobelt G, Langdon D, LeLorier J, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, et al. Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group. Multiple Sclerosis and Related Disorders. 4: 202-18. PMID 26008937 DOI: 10.1016/J.Msard.2015.02.005 |
0.346 |
|
| 2015 |
Cencioni MT, Santini S, Ruocco G, Borsellino G, De Bardi M, Grasso MG, Ruggieri S, Gasperini C, Centonze D, Barilá D, Battistini L, Volpe E. FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients. Cell Death & Disease. 6: e1741. PMID 25950471 DOI: 10.1038/Cddis.2015.100 |
0.316 |
|
| 2015 |
Musella A, Mandolesi G, Mori F, Gentile A, Centonze D. Linking synaptopathy and gray matter damage in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25921048 DOI: 10.1177/1352458515581875 |
0.313 |
|
| 2015 |
Parodi B, Rossi S, Morando S, Cordano C, Bragoni A, Motta C, Usai C, Wipke BT, Scannevin RH, Mancardi GL, Centonze D, Kerlero de Rosbo N, Uccelli A. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS. Acta Neuropathologica. 130: 279-95. PMID 25920452 DOI: 10.1007/S00401-015-1422-3 |
0.451 |
|
| 2015 |
Ruocco G, Rossi S, Motta C, Macchiarulo G, Barbieri F, De Bardi M, Borsellino G, Finardi A, Grasso MG, Ruggieri S, Gasperini C, Furlan R, Centonze D, Battistini L, Volpe E. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis. Clinical Science (London, England : 1979). 129: 291-303. PMID 25700150 DOI: 10.1042/Cs20140608 |
0.364 |
|
| 2015 |
Prosperini L, Annovazzi P, Capobianco M, Capra R, Buttari F, Gasperini C, Galgani S, Solaro C, Centonze D, Bertolotto A, Pozzilli C, Ghezzi A. Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25698174 DOI: 10.1177/1352458515570768 |
0.326 |
|
| 2015 |
Gentile A, Mori F, Bernardini S, Centonze D. Role of amyloid-β CSF levels in cognitive deficit in MS. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 25659291 DOI: 10.1016/J.Cca.2015.01.035 |
0.382 |
|
| 2015 |
Rossi S, Motta C, Studer V, Macchiarulo G, Germani G, Finardi A, Furlan R, Martino G, Centonze D. Subclinical central inflammation is risk for RIS and CIS conversion to MS. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25583841 DOI: 10.1177/1352458514564482 |
0.362 |
|
| 2015 |
Gentile A, Fresegna D, Federici M, Musella A, Rizzo FR, Sepman H, Bullitta S, De Vito F, Haji N, Rossi S, Mercuri NB, Usiello A, Mandolesi G, Centonze D. Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 74: 347-58. PMID 25511803 DOI: 10.1016/J.Nbd.2014.11.022 |
0.388 |
|
| 2015 |
Di Marzo V, Centonze D. Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes. Cns Neuroscience & Therapeutics. 21: 215-21. PMID 25475413 DOI: 10.1111/Cns.12358 |
0.33 |
|
| 2015 |
Mandolesi G, Gentile A, Musella A, Centonze D. IL-1β dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis. Cerebellum (London, England). 14: 19-22. PMID 25326653 DOI: 10.1007/S12311-014-0613-0 |
0.442 |
|
| 2015 |
Rossi S, Motta C, Musella A, Centonze D. The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission. Neuropharmacology. 96: 105-12. PMID 25268960 DOI: 10.1016/J.Neuropharm.2014.09.022 |
0.384 |
|
| 2014 |
Mori F, Ljoka C, Nicoletti CG, Kusayanagi H, Buttari F, Giordani L, Rossi S, Foti C, Centonze D. CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis. Neurology® Neuroimmunology & Neuroinflammation. 1: e48. PMID 25520956 DOI: 10.1212/Nxi.0000000000000048 |
0.364 |
|
| 2014 |
Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F, Ruocco G, Buttari F, Finardi A, Mancino R, Weiss S, Battistini L, Martino G, Furlan R, Drulovic J, ... Centonze D, et al. Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Molecular Neurodegeneration. 9: 56. PMID 25495224 DOI: 10.1186/1750-1326-9-56 |
0.337 |
|
| 2014 |
Studer V, Rossi S, Motta C, Buttari F, Centonze D. Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis. Journal of Neuroimmunology. 276: 229-31. PMID 25175066 DOI: 10.1016/J.Jneuroim.2014.08.617 |
0.313 |
|
| 2014 |
Errico F, Nisticò R, Di Giorgio A, Squillace M, Vitucci D, Galbusera A, Piccinin S, Mango D, Fazio L, Middei S, Trizio S, Mercuri NB, Teule MA, Centonze D, Gozzi A, et al. Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals. Translational Psychiatry. 4: e417. PMID 25072322 DOI: 10.1038/Tp.2014.59 |
0.324 |
|
| 2014 |
Stüve O, Warnke C, Deason K, Stangel M, Kieseier BC, Hartung HP, von Büdingen HC, Centonze D, Forsthuber TG, Knappertz V. CD19 as a molecular target in CNS autoimmunity. Acta Neuropathologica. 128: 177-90. PMID 24993505 DOI: 10.1007/S00401-014-1313-Z |
0.302 |
|
| 2014 |
Laricchiuta D, Musella A, Rossi S, Centonze D. Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli. Frontiers in Behavioral Neuroscience. 8: 183. PMID 24904335 DOI: 10.3389/Fnbeh.2014.00183 |
0.303 |
|
| 2014 |
Rossi S, Motta C, Studer V, Rocchi C, Macchiarulo G, Barbieri F, Marfia G, Furlan R, Martino G, Mancino R, Centonze D. Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1841-50. PMID 24876157 DOI: 10.1177/1352458514537365 |
0.307 |
|
| 2014 |
Rossi S, Motta C, Studer V, Boffa L, De Chiara V, Castelli M, Barbieri F, Buttari F, Monteleone F, Germani G, Macchiarulo G, Weiss S, Centonze D. Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids. Cns Neuroscience & Therapeutics. 20: 748-53. PMID 24837039 DOI: 10.1111/Cns.12282 |
0.359 |
|
| 2014 |
Weiss S, Mori F, Rossi S, Centonze D. Disability in multiple sclerosis: when synaptic long-term potentiation fails. Neuroscience and Biobehavioral Reviews. 43: 88-99. PMID 24726576 DOI: 10.1016/J.Neubiorev.2014.03.023 |
0.438 |
|
| 2014 |
Mori F, Nicoletti CG, Rossi S, Motta C, Kusayanagi H, Bergami A, Studer V, Buttari F, Barbieri F, Weiss S, Nisticò R, Martino G, Furlan R, Centonze D. Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis. Neuromolecular Medicine. 16: 490-8. PMID 24671722 DOI: 10.1007/S12017-014-8297-7 |
0.406 |
|
| 2014 |
Rossi S, Studer V, Motta C, Germani G, Macchiarulo G, Buttari F, Mancino R, Castelli M, De Chiara V, Weiss S, Martino G, Furlan R, Centonze D. Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis. Journal of Neuroinflammation. 11: 32. PMID 24548694 DOI: 10.1186/1742-2094-11-32 |
0.315 |
|
| 2014 |
Stefanini M, Fabiano S, Garaci F, Marziali S, Meschini A, Cama V, Fornari M, Rossi S, Centonze D, Gandini R, Simonetti G, Floris R. Phlebographic study does not show differences between patients with MS and control subjects. Ajnr. American Journal of Neuroradiology. 35: 1174-9. PMID 24524919 DOI: 10.3174/Ajnr.A3816 |
0.344 |
|
| 2014 |
Prosperini L, Mancinelli CR, Pozzilli C, Grasso MG, Clemenzi A, Collorone S, Pontecorvo S, Francia A, Villani V, Koudriavtseva T, Buttari F, Centonze D, Di Battista G, Frisullo G, Galgani S, et al. From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter study. European Neurology. 71: 233-41. PMID 24480868 DOI: 10.1159/000356786 |
0.314 |
|
| 2014 |
Musella A, Sepman H, Mandolesi G, Gentile A, Fresegna D, Haji N, Conrad A, Lutz B, Maccarrone M, Centonze D. Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis. Neuropharmacology. 79: 567-72. PMID 24440366 DOI: 10.1016/J.Neuropharm.2014.01.007 |
0.418 |
|
| 2014 |
Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Gallo A, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, et al. Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 35: 307-16. PMID 24374787 DOI: 10.1007/S10072-013-1616-1 |
0.35 |
|
| 2014 |
Nisticò R, Mori F, Feligioni M, Nicoletti F, Centonze D. Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 369: 20130162. PMID 24298163 DOI: 10.1098/Rstb.2013.0162 |
0.434 |
|
| 2014 |
Mori F, Kusayanagi H, Nicoletti CG, Weiss S, Marciani MG, Centonze D. Cortical plasticity predicts recovery from relapse in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 451-7. PMID 24263385 DOI: 10.1177/1352458513512541 |
0.401 |
|
| 2014 |
Mori F, Nisticò R, Mandolesi G, Piccinin S, Mango D, Kusayanagi H, Berretta N, Bergami A, Gentile A, Musella A, Nicoletti CG, Nicoletti F, Buttari F, Mercuri NB, Martino G, ... ... Centonze D, et al. Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis. Neuromolecular Medicine. 16: 38-51. PMID 23892937 DOI: 10.1007/S12017-013-8249-7 |
0.443 |
|
| 2014 |
Rossi S, Motta C, Studer V, Barbieri F, Buttari F, Bergami A, Sancesario G, Bernardini S, De Angelis G, Martino G, Furlan R, Centonze D. Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 304-12. PMID 23886826 DOI: 10.1177/1352458513498128 |
0.432 |
|
| 2014 |
Bacigaluppi M, Russo GL, Peruzzotti-jametti L, Rossi S, Butti E, Ceglia RD, Motta C, Muzio L, Comi G, Centonze D, Invernizzi RW, Hermann DM, Martino G. Neural stem cell transplantation promotes post-ischemic neuronal plasticity by regulating the expression of glutamate transporters Journal of Neuroimmunology. 275: 188. DOI: 10.1016/J.Jneuroim.2014.08.506 |
0.317 |
|
| 2013 |
Rossi S, Bozzali M, Bari M, Mori F, Studer V, Motta C, Buttari F, Cercignani M, Gravina P, Mastrangelo N, Castelli M, Mancino R, Nucci C, Sottile F, Bernardini S, ... ... Centonze D, et al. Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis. Plos One. 8: e82848. PMID 24391723 DOI: 10.1371/Journal.Pone.0082848 |
0.398 |
|
| 2013 |
Basile B, Castelli M, Monteleone F, Nocentini U, Caltagirone C, Centonze D, Cercignani M, Bozzali M. Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1050-1057. PMID 24326671 DOI: 10.1177/1352458513515082 |
0.33 |
|
| 2013 |
Mori F, Rossi S, Piccinin S, Motta C, Mango D, Kusayanagi H, Bergami A, Studer V, Nicoletti CG, Buttari F, Barbieri F, Mercuri NB, Martino G, Furlan R, Nisticò R, ... Centonze D, et al. Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19112-9. PMID 24305808 DOI: 10.1523/Jneurosci.2536-13.2013 |
0.441 |
|
| 2013 |
Musella A, Mandolesi G, Gentile A, Rossi S, Studer V, Motta C, Sepman H, Fresegna D, Haji N, Paolillo A, Matarese G, Centonze D. Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis. Journal of Neuroimmunology. 264: 8-13. PMID 24045165 DOI: 10.1016/J.Jneuroim.2013.08.009 |
0.461 |
|
| 2013 |
Mandolesi G, Musella A, Gentile A, Grasselli G, Haji N, Sepman H, Fresegna D, Bullitta S, De Vito F, Musumeci G, Di Sanza C, Strata P, Centonze D. Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 12105-21. PMID 23864696 DOI: 10.1523/Jneurosci.5369-12.2013 |
0.723 |
|
| 2013 |
De Chiara V, Motta C, Rossi S, Studer V, Barbieri F, Lauro D, Bernardi G, Centonze D. Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum. Neuroscience. 250: 232-9. PMID 23856068 DOI: 10.1016/J.Neuroscience.2013.06.069 |
0.32 |
|
| 2013 |
Rossi S, Studer V, Moscatelli A, Motta C, Coghe G, Fenu G, Caillier S, Buttari F, Mori F, Barbieri F, Castelli M, De Chiara V, Monteleone F, Mancino R, Bernardi G, ... ... Centonze D, et al. Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis. Plos One. 8: e67357. PMID 23840674 DOI: 10.1371/Journal.Pone.0067357 |
0.413 |
|
| 2013 |
Bari M, Battista N, Valenza M, Mastrangelo N, Malaponti M, Catanzaro G, Centonze D, Finazzi-Agrò A, Cattaneo E, Maccarrone M. In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system. The Febs Journal. 280: 3376-88. PMID 23659592 DOI: 10.1111/Febs.12329 |
0.317 |
|
| 2013 |
Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. Plos Pathogens. 9: e1003220. PMID 23592979 DOI: 10.1371/Journal.Ppat.1003220 |
0.349 |
|
| 2013 |
Chiurchiù V, Cencioni MT, Bisicchia E, De Bardi M, Gasperini C, Borsellino G, Centonze D, Battistini L, Maccarrone M. Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis. Annals of Neurology. 73: 626-36. PMID 23447381 DOI: 10.1002/Ana.23875 |
0.388 |
|
| 2013 |
Gentile A, Rossi S, Studer V, Motta C, De Chiara V, Musella A, Sepman H, Fresegna D, Musumeci G, Grasselli G, Haji N, Weiss S, Hayardeny L, Mandolesi G, Centonze D. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 651-63. PMID 23370991 DOI: 10.1007/S11481-013-9436-X |
0.596 |
|
| 2013 |
Nisticò R, Mango D, Mandolesi G, Piccinin S, Berretta N, Pignatelli M, Feligioni M, Musella A, Gentile A, Mori F, Bernardi G, Nicoletti F, Mercuri NB, Centonze D. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. Plos One. 8: e54666. PMID 23355887 DOI: 10.1371/Journal.Pone.0054666 |
0.416 |
|
| 2013 |
Bozzali M, Spanò B, Parker GJ, Giulietti G, Castelli M, Basile B, Rossi S, Serra L, Magnani G, Nocentini U, Caltagirone C, Centonze D, Cercignani M. Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1161-8. PMID 23325589 DOI: 10.1177/1352458512474088 |
0.338 |
|
| 2013 |
Pieragostino D, Del Boccio P, Di Ioia M, Pieroni L, Greco V, De Luca G, D'Aguanno S, Rossi C, Franciotta D, Centonze D, Sacchetta P, Di Ilio C, Lugaresi A, Urbani A. Oxidative modifications of cerebral transthyretin are associated with multiple sclerosis. Proteomics. 13: 1002-9. PMID 23319365 DOI: 10.1002/Pmic.201200395 |
0.309 |
|
| 2013 |
Ruffini F, Rossi S, Bergamaschi A, Brambilla E, Finardi A, Motta C, Studer V, Barbieri F, De Chiara V, Hayardeny L, Comi G, Centonze D, Martino G. Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1084-94. PMID 23232603 DOI: 10.1177/1352458512469698 |
0.428 |
|
| 2013 |
Mori F, Nicoletti CG, Kusayanagi H, Foti C, Restivo DA, Marciani MG, Centonze D. Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis. Brain Stimulation. 6: 654-9. PMID 23122918 DOI: 10.1016/J.Brs.2012.10.003 |
0.329 |
|
| 2013 |
Restivo DA, Casabona A, Centonze D, Marchese-Ragona R, Maimone D, Pavone A. Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: a pilot study. Brain Stimulation. 6: 418-23. PMID 23040375 DOI: 10.1016/J.Brs.2012.09.001 |
0.342 |
|
| 2013 |
Rieckmann P, Boyko A, Centonze D, Coles A, Elovaara I, Havrdová E, Hommes O, Lelorier J, Morrow SA, Oreja-Guevara C, Rijke N, Schippling S. Future MS care: a consensus statement of the MS in the 21st Century Steering Group. Journal of Neurology. 260: 462-9. PMID 22936203 DOI: 10.1007/S00415-012-6656-6 |
0.35 |
|
| 2013 |
Grasselli G, Rossi S, Musella A, Gentile A, Loizzo S, Muzio L, Di Sanza C, Errico F, Musumeci G, Haji N, Fresegna D, Sepman H, De Chiara V, Furlan R, Martino G, ... ... Centonze D, et al. Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis. British Journal of Pharmacology. 168: 502-17. PMID 22924679 DOI: 10.1111/J.1476-5381.2012.02178.X |
0.621 |
|
| 2013 |
Rossi S, Motta C, Studer V, De Chiara V, Barbieri F, Monteleone F, Fornasiero A, Coarelli G, Bernardi G, Cutter G, Stüve O, Salvetti M, Centonze D. Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 87-94. PMID 22741530 DOI: 10.1111/J.1468-1331.2012.03794.X |
0.34 |
|
| 2013 |
Rossi S, Motta C, Studer V, Monteleone F, De Chiara V, Buttari F, Barbieri F, Bernardi G, Battistini L, Cutter G, Stüve O, Salvetti M, Centonze D. A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 59-68. PMID 22577119 DOI: 10.1177/1352458512448106 |
0.36 |
|
| 2013 |
Mori F, Kusayanagi H, Monteleone F, Moscatelli A, Nicoletti CG, Bernardi G, Centonze D. Short interval intracortical facilitation correlates with the degree of disability in multiple sclerosis. Brain Stimulation. 6: 67-71. PMID 22425067 DOI: 10.1016/J.Brs.2012.02.001 |
0.395 |
|
| 2012 |
Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, Musella A, Barbieri F, Bari M, Bernardi G, Maccarrone M, Usiello A, Centonze D. Interleukin-1β causes anxiety by interacting with the endocannabinoid system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 13896-905. PMID 23035099 DOI: 10.1523/Jneurosci.1515-12.2012 |
0.311 |
|
| 2012 |
Centonze D, Rossi S, Rinaldi F, Gallo P. Severe relapses under fingolimod treatment prescribed after natalizumab. Neurology. 79: 2004-5. PMID 23035063 DOI: 10.1212/Wnl.0B013E3182735C7A |
0.35 |
|
| 2012 |
Garaci FG, Marziali S, Meschini A, Fornari M, Rossi S, Melis M, Fabiano S, Stefanini M, Simonetti G, Centonze D, Floris R. Brain hemodynamic changes associated with chronic cerebrospinal venous insufficiency are not specific to multiple sclerosis and do not increase its severity. Radiology. 265: 233-9. PMID 22915599 DOI: 10.1148/Radiol.12112245 |
0.367 |
|
| 2012 |
Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S, Musella A, Sepman H, Motta C, Studer V, De Chiara V, Bernardi G, Strata P, Centonze D. TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Experimental Neurology. 237: 296-303. PMID 22836148 DOI: 10.1016/J.Expneurol.2012.07.010 |
0.612 |
|
| 2012 |
Rossi S, Studer V, Motta C, De Chiara V, Barbieri F, Bernardi G, Centonze D. Inflammation inhibits GABA transmission in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1633-5. PMID 22419673 DOI: 10.1177/1352458512440207 |
0.415 |
|
| 2012 |
Laricchiuta D, Rossi S, Musella A, De Chiara V, Cutuli D, Centonze D, Petrosini L. Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission. Plos One. 7: e33260. PMID 22413007 DOI: 10.1371/Journal.Pone.0033260 |
0.318 |
|
| 2012 |
Mandolesi G, Grasselli G, Musella A, Gentile A, Musumeci G, Sepman H, Haji N, Fresegna D, Bernardi G, Centonze D. GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 46: 414-24. PMID 22349452 DOI: 10.1016/J.Nbd.2012.02.005 |
0.654 |
|
| 2012 |
Rossi S, Furlan R, De Chiara V, Motta C, Studer V, Mori F, Musella A, Bergami A, Muzio L, Bernardi G, Battistini L, Martino G, Centonze D. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Annals of Neurology. 71: 76-83. PMID 22275254 DOI: 10.1002/Ana.22512 |
0.439 |
|
| 2012 |
Floris R, Centonze D, Fabiano S, Stefanini M, Marziali S, Del Giudice C, Reale CA, Castelli M, Garaci F, Melis M, Gandini R, Simonetti G. Prevalence study of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: preliminary data. La Radiologia Medica. 117: 855-64. PMID 22228125 DOI: 10.1007/S11547-011-0767-5 |
0.368 |
|
| 2012 |
Rossi S, Lo Giudice T, De Chiara V, Musella A, Studer V, Motta C, Bernardi G, Martino G, Furlan R, Martorana A, Centonze D. Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis. British Journal of Pharmacology. 165: 861-9. PMID 21740406 DOI: 10.1111/J.1476-5381.2011.01579.X |
0.459 |
|
| 2012 |
Gironi M, Pasquariello N, Franchi S, Pucci M, Martinelli-Boneschi F, Solaro C, Centonze D, Martino G, Sacerdote P, Maccarrone M. Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis". Brain Pathology (Zurich, Switzerland). 22: 79. PMID 21707818 DOI: 10.1111/J.1750-3639.2011.00511.X |
0.317 |
|
| 2012 |
Mori F, Kusayanagi H, Buttari F, Nicoletti CG, Bernardi G, Centonze D. Glatiramer Acetate Reverses Plasticity and Cognitive Deficits Associated with Acute Inflammation in MS (P04.118) Neurology. 78: P04.118-P04.118. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P04.118 |
0.381 |
|
| 2011 |
Castelli M, Federici M, Rossi S, De Chiara V, Napolitano F, Studer V, Motta C, Sacchetti L, Romano R, Musella A, Bernardi G, Siracusano A, Gu HH, Mercuri NB, Usiello A, ... Centonze D, et al. Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter. The European Journal of Neuroscience. 34: 1369-77. PMID 22034972 DOI: 10.1111/J.1460-9568.2011.07876.X |
0.302 |
|
| 2011 |
Centonze D, Floris R, Stefanini M, Rossi S, Fabiano S, Castelli M, Marziali S, Spinelli A, Motta C, Garaci FG, Bernardi G, Simonetti G. Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Annals of Neurology. 70: 51-8. PMID 21786298 DOI: 10.1002/Ana.22436 |
0.379 |
|
| 2011 |
Mori F, Ribolsi M, Kusayanagi H, Siracusano A, Mantovani V, Marasco E, Bernardi G, Centonze D. Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans. Journal of Neurophysiology. 106: 1637-43. PMID 21753020 DOI: 10.1152/Jn.00318.2011 |
0.324 |
|
| 2011 |
Dalla Libera D, Di Mitri D, Bergami A, Centonze D, Gasperini C, Grasso MG, Galgani S, Martinelli V, Comi G, Avolio C, Martino G, Borsellino G, Sallusto F, Battistini L, Furlan R. T regulatory cells are markers of disease activity in multiple sclerosis patients. Plos One. 6: e21386. PMID 21731726 DOI: 10.1371/Journal.Pone.0021386 |
0.36 |
|
| 2011 |
Rossi S, Mancino R, Bergami A, Mori F, Castelli M, De Chiara V, Studer V, Mataluni G, Sancesario G, Parisi V, Kusayanagi H, Bernardi G, Nucci C, Bernardini S, Martino G, ... ... Centonze D, et al. Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1301-12. PMID 21677024 DOI: 10.1177/1352458511410342 |
0.386 |
|
| 2011 |
Musumeci G, Grasselli G, Rossi S, De Chiara V, Musella A, Motta C, Studer V, Bernardi G, Haji N, Sepman H, Fresegna D, Maccarrone M, Mandolesi G, Centonze D. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 43: 669-77. PMID 21672630 DOI: 10.1016/J.Nbd.2011.05.018 |
0.618 |
|
| 2011 |
Rossi S, Furlan R, De Chiara V, Muzio L, Musella A, Motta C, Studer V, Cavasinni F, Bernardi G, Martino G, Cravatt BF, Lutz B, Maccarrone M, Centonze D. Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 25: 1242-8. PMID 21473912 DOI: 10.1016/J.Bbi.2011.03.017 |
0.441 |
|
| 2011 |
Hasan SK, Buttari F, Ottone T, Voso MT, Hohaus S, Marasco E, Mantovani V, Garagnani P, Sanz MA, Cicconi L, Bernardi G, Centonze D, Lo-Coco F. Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes. Neurology. 76: 1059-65. PMID 21346221 DOI: 10.1212/Wnl.0B013E318211C3C8 |
0.306 |
|
| 2011 |
Maccarrone M, Bernardi G, Agrò AF, Centonze D. Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance. British Journal of Pharmacology. 163: 1379-90. PMID 21323908 DOI: 10.1111/J.1476-5381.2011.01277.X |
0.309 |
|
| 2011 |
Bagnato F, Centonze D, Galgani S, Grasso MG, Haggiag S, Strano S. Painful and involuntary multiple sclerosis. Expert Opinion On Pharmacotherapy. 12: 763-77. PMID 21323633 DOI: 10.1517/14656566.2011.540239 |
0.318 |
|
| 2011 |
Mori F, Ljoka C, Magni E, Codecà C, Kusayanagi H, Monteleone F, Sancesario A, Bernardi G, Koch G, Foti C, Centonze D. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology. 258: 1281-7. PMID 21286740 DOI: 10.1007/S00415-011-5924-1 |
0.34 |
|
| 2011 |
Ghezzi A, Grimaldi LM, Marrosu MG, Pozzilli C, Comi G, Bertolotto A, Trojano M, Gallo P, Capra R, Centonze D, Millefiorini E, Sotgiu S, Brescia Morra V, Amato MP, Lugaresi A, et al. Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological Society. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 32: 351-8. PMID 21234775 DOI: 10.1007/S10072-010-0469-0 |
0.372 |
|
| 2011 |
Cutuli D, Rossi S, Burello L, Laricchiuta D, De Chiara V, Foti F, De Bartolo P, Musella A, Gelfo F, Centonze D, Petrosini L. Before or after does it matter? Different protocols of environmental enrichment differently influence motor, synaptic and structural deficits of cerebellar origin. Neurobiology of Disease. 42: 9-20. PMID 21182946 DOI: 10.1016/J.Nbd.2010.12.007 |
0.37 |
|
| 2011 |
Rossi S, Buttari F, Studer V, Motta C, Gravina P, Castelli M, Mantovani V, De Chiara V, Musella A, Fiore S, Masini S, Bernardi G, Maccarrone M, Bernardini S, Centonze D. The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 281-8. PMID 21148019 DOI: 10.1177/1352458510388680 |
0.391 |
|
| 2011 |
Mori F, Rossi S, Sancesario G, Codecà C, Mataluni G, Monteleone F, Buttari F, Kusayanagi H, Castelli M, Motta C, Studer V, Bernardi G, Koch G, Bernardini S, Centonze D. Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 559-68. PMID 20944553 DOI: 10.1038/Npp.2010.187 |
0.352 |
|
| 2011 |
Rossi S, Muzio L, De Chiara V, Grasselli G, Musella A, Musumeci G, Mandolesi G, De Ceglia R, Maida S, Biffi E, Pedrocchi A, Menegon A, Bernardi G, Furlan R, Martino G, ... Centonze D, et al. Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 25: 947-56. PMID 20940040 DOI: 10.1016/J.Bbi.2010.10.004 |
0.635 |
|
| 2010 |
Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, et al. Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Annals of Neurology. 68: 409-11. PMID 20818795 DOI: 10.1002/Ana.22083 |
0.326 |
|
| 2010 |
Codecà C, Mori F, Kusayanagi H, Monteleone F, Boffa L, Paolillo A, Bernardi G, Koch G, Centonze D. Differential patterns of interhemispheric functional disconnection in mild and advanced multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 1308-16. PMID 20702503 DOI: 10.1177/1352458510376957 |
0.359 |
|
| 2010 |
Rossi S, De Chiara V, Furlan R, Musella A, Cavasinni F, Muzio L, Bernardi G, Martino G, Centonze D. Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 24: 1379-85. PMID 20647042 DOI: 10.1016/J.Bbi.2010.07.241 |
0.353 |
|
| 2010 |
Mandolesi G, Grasselli G, Musumeci G, Centonze D. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 31: S255-9. PMID 20635112 DOI: 10.1007/S10072-010-0369-3 |
0.63 |
|
| 2010 |
Rossi S, De Chiara V, Musella A, Sacchetti L, Cantarella C, Castelli M, Cavasinni F, Motta C, Studer V, Bernardi G, Cravatt BF, Maccarrone M, Usiello A, Centonze D. Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition. Molecular Pharmacology. 78: 260-8. PMID 20424126 DOI: 10.1124/Mol.110.064196 |
0.348 |
|
| 2010 |
Maccarrone M, Rossi S, Bari M, De Chiara V, Rapino C, Musella A, Bernardi G, Bagni C, Centonze D. Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1500-9. PMID 20393458 DOI: 10.1038/Npp.2010.19 |
0.592 |
|
| 2010 |
Rossi S, Bernardi G, Centonze D. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis. Experimental Neurology. 224: 92-102. PMID 20353778 DOI: 10.1016/J.Expneurol.2010.03.030 |
0.386 |
|
| 2010 |
Musella A, De Chiara V, Rossi S, Cavasinni F, Castelli M, Cantarella C, Mataluni G, Bernardi G, Centonze D. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. Neuroscience. 167: 864-71. PMID 20219639 DOI: 10.1016/J.Neuroscience.2010.02.058 |
0.349 |
|
| 2010 |
Rossi S, De Chiara V, Musella A, Mataluni G, Sacchetti L, Siracusano A, Bernardi G, Usiello A, Centonze D. Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors. Molecular Nutrition & Food Research. 54: 525-31. PMID 20087854 DOI: 10.1002/Mnfr.200900237 |
0.321 |
|
| 2010 |
Spanò B, Cercignani M, Basile B, Romano S, Mannu R, Centonze D, Caltagirone C, Bramanti P, Nocentini U, Bozzali M. Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 178-88. PMID 20007429 DOI: 10.1177/1352458509356010 |
0.344 |
|
| 2010 |
Centonze D, Muzio L, Rossi S, Furlan R, Bernardi G, Martino G. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death and Differentiation. 17: 1083-91. PMID 19927157 DOI: 10.1038/Cdd.2009.179 |
0.459 |
|
| 2010 |
Mori F, Codecà C, Kusayanagi H, Monteleone F, Boffa L, Rimano A, Bernardi G, Koch G, Centonze D. Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 295-300. PMID 19863647 DOI: 10.1111/J.1468-1331.2009.02806.X |
0.36 |
|
| 2010 |
De Chiara V, Errico F, Musella A, Rossi S, Mataluni G, Sacchetti L, Siracusano A, Castelli M, Cavasinni F, Bernardi G, Usiello A, Centonze D. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 374-87. PMID 19776732 DOI: 10.1038/Npp.2009.141 |
0.371 |
|
| 2010 |
Rossi S, De Chiara V, Musella A, Cozzolino M, Bernardi G, Maccarrone M, Mercuri NB, Carrì MT, Centonze D. Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 83-90. PMID 19452308 DOI: 10.3109/17482960902977954 |
0.392 |
|
| 2009 |
Koch G, Mori F, Codecà C, Kusayanagi H, Monteleone F, Buttari F, Fiore S, Bernardi G, Centonze D. Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans. Brain Stimulation. 2: 229-33. PMID 20633421 DOI: 10.1016/J.Brs.2009.03.001 |
0.346 |
|
| 2009 |
Centonze D, Mori F, Koch G, Buttari F, Codecà C, Rossi S, Cencioni MT, Bari M, Fiore S, Bernardi G, Battistini L, Maccarrone M. Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 30: 531-4. PMID 19768368 DOI: 10.1007/S10072-009-0136-5 |
0.383 |
|
| 2009 |
D'Argenzio L, Koch G, Bombardieri R, Mori F, Moavero R, Centonze D, Curatolo P. Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex. Epilepsy Research. 87: 102-5. PMID 19713078 DOI: 10.1016/J.Eplepsyres.2009.07.009 |
0.303 |
|
| 2009 |
Mori F, Koch G, Foti C, Bernardi G, Centonze D. The use of repetitive transcranial magnetic stimulation (rTMS) for the treatment of spasticity. Progress in Brain Research. 175: 429-39. PMID 19660671 DOI: 10.1016/S0079-6123(09)17528-3 |
0.333 |
|
| 2009 |
Rossi S, Furlan R, De Chiara V, Musella A, Lo Giudice T, Mataluni G, Cavasinni F, Cantarella C, Bernardi G, Muzio L, Martorana A, Martino G, Centonze D. Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis. Neurobiology of Disease. 36: 51-9. PMID 19591937 DOI: 10.1016/J.Nbd.2009.06.013 |
0.35 |
|
| 2009 |
Rossi S, Mataluni G, Codecà C, Fiore S, Buttari F, Musella A, Castelli M, Bernardi G, Centonze D. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 360-6. PMID 19364364 DOI: 10.1111/J.1468-1331.2008.02496.X |
0.309 |
|
| 2009 |
Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, Musella A, D'Amelio M, Cavallucci V, Martorana A, Bergamaschi A, Cencioni MT, Diamantini A, Butti E, Comi G, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 3442-52. PMID 19295150 DOI: 10.1523/Jneurosci.5804-08.2009 |
0.396 |
|
| 2009 |
Rossi S, De Chiara V, Musella A, Mataluni G, Sacchetti L, Bernardi G, Usiello A, Centonze D. Adaptations of striatal endocannabinoid system during stress. Molecular Neurobiology. 39: 178-84. PMID 19267225 DOI: 10.1007/S12035-009-8061-4 |
0.308 |
|
| 2009 |
Maccarrone M, De Chiara V, Gasperi V, Viscomi MT, Rossi S, Oddi S, Molinari M, Musella A, Finazzi-Agrò A, Centonze D. Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum. Journal of Neurochemistry. 109: 371-81. PMID 19187444 DOI: 10.1111/J.1471-4159.2009.05948.X |
0.341 |
|
| 2009 |
Rossi S, De Chiara V, Musella A, Mataluni G, Sacchetti L, Siracusano A, Bernardi G, Usiello A, Centonze D. Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects. Neuropharmacology. 56: 590-7. PMID 19027757 DOI: 10.1016/J.Neuropharm.2008.10.013 |
0.337 |
|
| 2009 |
Tashev R, Moura PJ, Venkitaramani DV, Prosperetti C, Centonze D, Paul S, Lombroso PJ. A substrate trapping mutant form of striatal-enriched protein tyrosine phosphatase prevents amphetamine-induced stereotypies and long-term potentiation in the striatum. Biological Psychiatry. 65: 637-45. PMID 19026408 DOI: 10.1016/J.Biopsych.2008.10.008 |
0.304 |
|
| 2009 |
Musella A, De Chiara V, Rossi S, Prosperetti C, Bernardi G, Maccarrone M, Centonze D. TRPV1 channels facilitate glutamate transmission in the striatum. Molecular and Cellular Neurosciences. 40: 89-97. PMID 18930149 DOI: 10.1016/J.Mcn.2008.09.001 |
0.342 |
|
| 2009 |
Gironi M, Pasquariello N, Franchi S, Sacerdote P, Martino G, Martinelli-Boneschi F, Martinelli V, Comi G, Nemni R, Solaro C, Centonze D, Maccarone M. FP48-TH-05 Study of low dose naltrexone modulation of the endocannabinoid system in patients with multiple sclerosis Journal of the Neurological Sciences. 285. DOI: 10.1016/S0022-510X(09)70527-1 |
0.307 |
|
| 2008 |
Centonze D, Battistini L, Maccarrone M. The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases. Current Pharmaceutical Design. 14: 2370-42. PMID 18781987 DOI: 10.2174/138161208785740018 |
0.313 |
|
| 2008 |
Centonze D, Furlan R, Gasperini C, Salvetti M, Battistini L. Early relapses after the first dose of natalizumab in active multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 1137-8. PMID 18701574 DOI: 10.1177/1352458508092810 |
0.341 |
|
| 2008 |
Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, Usiello A, Centonze D. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7284-92. PMID 18632932 DOI: 10.1523/Jneurosci.5346-07.2008 |
0.339 |
|
| 2008 |
Koch G, Rossi S, Prosperetti C, Codecà C, Monteleone F, Petrosini L, Bernardi G, Centonze D. Improvement of hand dexterity following motor cortex rTMS in multiple sclerosis patients with cerebellar impairment. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 995-8. PMID 18573820 DOI: 10.1177/1352458508088710 |
0.34 |
|
| 2008 |
Centonze D, Rossi S, De Bartolo P, De Chiara V, Foti F, Musella A, Mataluni G, Rossi S, Bernardi G, Koch G, Petrosini L. Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage. The European Journal of Neuroscience. 27: 2188-96. PMID 18412636 DOI: 10.1111/J.1460-9568.2008.06182.X |
0.381 |
|
| 2008 |
Napolitano M, Zei D, Centonze D, Palermo R, Bernardi G, Vacca A, Calabresi P, Gulino A. NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease. Neuroscience Letters. 434: 241-6. PMID 18329171 DOI: 10.1016/J.Neulet.2007.09.056 |
0.301 |
|
| 2008 |
Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A, Gasperi V, Prosperetti C, Bernardi G, Finazzi-Agrò A, Cravatt BF, Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nature Neuroscience. 11: 152-9. PMID 18204441 DOI: 10.1038/Nn2042 |
0.301 |
|
| 2008 |
Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V, Carta M, De Chiara V, Prosperetti C, Spano D, Herve D, Pasqualetti M, Di Lauro R, Fisone G, Usiello A. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Molecular and Cellular Neurosciences. 37: 335-45. PMID 18035555 DOI: 10.1016/J.Mcn.2007.10.007 |
0.305 |
|
| 2008 |
Centonze D, Rossi S, Mercaldo V, Napoli I, Ciotti MT, De Chiara V, Musella A, Prosperetti C, Calabresi P, Bernardi G, Bagni C. Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biological Psychiatry. 63: 963-73. PMID 18028882 DOI: 10.1016/J.Biopsych.2007.09.008 |
0.6 |
|
| 2008 |
Errico F, Nisticò R, Palma G, Federici M, Affuso A, Brilli E, Topo E, Centonze D, Bernardi G, Bozzi Y, D'Aniello A, Di Lauro R, Mercuri NB, Usiello A. Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility. Molecular and Cellular Neurosciences. 37: 236-46. PMID 17981050 DOI: 10.1016/J.Mcn.2007.09.012 |
0.316 |
|
| 2008 |
Bari M, Oddi S, De Simone C, Spagnolo P, Gasperi V, Battista N, Centonze D, Maccarrone M. Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. Neuropharmacology. 54: 45-50. PMID 17714745 DOI: 10.1016/J.Neuropharm.2007.06.030 |
0.301 |
|
| 2008 |
Mori F, Codecà C, Kusayanagi H, Monteleone F, Koch G, Centonze D. Effect of Sativex® chronic therapy on TBS modulation of motor cortex excitability in MS patients Brain Stimulation. 1: 262. DOI: 10.1016/J.Brs.2008.06.051 |
0.329 |
|
| 2008 |
Codecà C, Mori F, Kusayanagi H, Monteleone F, Centonze D, Koch G. iTBS of primary motor cortex improves spasticity in MS patients Brain Stimulation. 1: 267. DOI: 10.1016/J.Brs.2008.06.014 |
0.326 |
|
| 2007 |
Centonze D, Bernardi G, Koch G. Mechanisms of disease: basic-research-driven investigations in humans--the case of hyperkinetic disorders. Nature Clinical Practice. Neurology. 3: 572-80. PMID 17914345 DOI: 10.1038/Ncpneuro0617 |
0.345 |
|
| 2007 |
Tozzi A, Tscherter A, Belcastro V, Tantucci M, Costa C, Picconi B, Centonze D, Calabresi P, Borsini F. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission. Neuropharmacology. 53: 783-9. PMID 17889039 DOI: 10.1016/J.Neuropharm.2007.08.006 |
0.356 |
|
| 2007 |
Centonze D, Rossi S, Napoli I, Mercaldo V, Lacoux C, Ferrari F, Ciotti MT, De Chiara V, Prosperetti C, Maccarrone M, Fezza F, Calabresi P, Bernardi G, Bagni C. The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8885-92. PMID 17699670 DOI: 10.1523/Jneurosci.0548-07.2007 |
0.586 |
|
| 2007 |
Centonze D, Rossi S, Finazzi-Agrò A, Bernardi G, Maccarrone M. The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis. International Review of Neurobiology. 82: 171-86. PMID 17678961 DOI: 10.1016/S0074-7742(07)82009-5 |
0.397 |
|
| 2007 |
Centonze D, Bari M, Rossi S, Prosperetti C, Furlan R, Fezza F, De Chiara V, Battistini L, Bernardi G, Bernardini S, Martino G, Maccarrone M. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain : a Journal of Neurology. 130: 2543-53. PMID 17626034 DOI: 10.1093/Brain/Awm160 |
0.448 |
|
| 2007 |
Centonze D, Rossi S, Tortiglione A, Picconi B, Prosperetti C, De Chiara V, Bernardi G, Calabresi P. Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery. Neurobiology of Disease. 27: 44-53. PMID 17490888 DOI: 10.1016/J.Nbd.2007.03.012 |
0.371 |
|
| 2007 |
Centonze D, Petta F, Versace V, Rossi S, Torelli F, Prosperetti C, Rossi S, Marfia GA, Bernardi G, Koch G, Miano R, Boffa L, Finazzi-Agrò E. Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13: 269-71. PMID 17439897 DOI: 10.1177/1352458506070729 |
0.331 |
|
| 2007 |
Centonze D, Rossi S, Prosperetti C, Gasperi V, De Chiara V, Bari M, Tscherter A, Febbraro F, Bernardi G, Maccarrone M. Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons. Molecular and Cellular Neurosciences. 35: 302-10. PMID 17434747 DOI: 10.1016/J.Mcn.2007.03.005 |
0.392 |
|
| 2007 |
Tortiglione A, Picconi B, Barone I, Centonze D, Rossi S, Costa C, Di Filippo M, Tozzi A, Tantucci M, Bernardi G, Annunziato L, Calabresi P. Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. Stroke; a Journal of Cerebral Circulation. 38: 1614-20. PMID 17395860 DOI: 10.1161/Strokeaha.106.478644 |
0.306 |
|
| 2007 |
Centonze D, Koch G, Versace V, Mori F, Rossi S, Brusa L, Grossi K, Torelli F, Prosperetti C, Cervellino A, Marfia GA, Stanzione P, Marciani MG, Boffa L, Bernardi G. Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis. Neurology. 68: 1045-50. PMID 17389310 DOI: 10.1212/01.Wnl.0000257818.16952.62 |
0.304 |
|
| 2007 |
Centonze D, Finazzi-Agrò A, Bernardi G, Maccarrone M. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends in Pharmacological Sciences. 28: 180-7. PMID 17350694 DOI: 10.1016/J.Tips.2007.02.004 |
0.303 |
|
| 2007 |
Maccarrone M, Battista N, Centonze D. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Progress in Neurobiology. 81: 349-79. PMID 17276576 DOI: 10.1016/J.Pneurobio.2006.11.006 |
0.33 |
|
| 2006 |
Rossi S, Prosperetti C, Picconi B, De Chiara V, Mataluni G, Bernardi G, Calabresi P, Centonze D. Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. Neuroscience Letters. 410: 6-10. PMID 17070651 DOI: 10.1016/J.Neulet.2006.09.056 |
0.364 |
|
| 2006 |
Centonze D, Rossi S, Gubellini P, De Chiara V, Tscherter A, Prosperetti C, Picconi B, Bernardi G, Calabresi P, Baunez C. Deficits of glutamate transmission in the striatum of experimental hemiballism. Neuroscience. 143: 213-21. PMID 16938405 DOI: 10.1016/J.Neuroscience.2006.07.024 |
0.337 |
|
| 2006 |
Centonze D, Prosperetti C, Barone I, Rossi S, Picconi B, Tscherter A, De Chiara V, Bernardi G, Calabresi P. NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum. Experimental Neurology. 202: 470-9. PMID 16919272 DOI: 10.1016/J.Expneurol.2006.07.009 |
0.346 |
|
| 2006 |
Brusa L, Versace V, Koch G, Iani C, Stanzione P, Bernardi G, Centonze D. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 117: 1917-21. PMID 16887383 DOI: 10.1016/J.Clinph.2006.03.033 |
0.3 |
|
| 2006 |
Picconi B, Tortiglione A, Barone I, Centonze D, Gardoni F, Gubellini P, Bonsi P, Pisani A, Bernardi G, Di Luca M, Calabresi P. NR2B subunit exerts a critical role in postischemic synaptic plasticity. Stroke; a Journal of Cerebral Circulation. 37: 1895-901. PMID 16741178 DOI: 10.1161/01.Str.0000226981.57777.B0 |
0.353 |
|
| 2006 |
Allen PB, Zachariou V, Svenningsson P, Lepore AC, Centonze D, Costa C, Rossi S, Bender G, Chen G, Feng J, Snyder GL, Bernardi G, Nestler EJ, Yan Z, Calabresi P, et al. Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience. 140: 897-911. PMID 16600521 DOI: 10.1016/J.Neuroscience.2006.02.067 |
0.353 |
|
| 2006 |
Centonze D, Costa C, Rossi S, Prosperetti C, Pisani A, Usiello A, Bernardi G, Mercuri NB, Calabresi P. Chronic cocaine prevents depotentiation at corticostriatal synapses. Biological Psychiatry. 60: 436-43. PMID 16476411 DOI: 10.1016/J.Biopsych.2005.11.018 |
0.303 |
|
| 2005 |
Koch G, Brusa L, Caltagirone C, Peppe A, Oliveri M, Stanzione P, Centonze D. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology. 65: 623-5. PMID 16116131 DOI: 10.1212/01.Wnl.0000172861.36430.95 |
0.308 |
|
| 2005 |
Bonsi P, Cuomo D, De Persis C, Centonze D, Bernardi G, Calabresi P, Pisani A. Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons. Neuropharmacology. 49: 104-13. PMID 16005029 DOI: 10.1016/J.Neuropharm.2005.05.012 |
0.355 |
|
| 2005 |
Centonze D, Rossi S, Prosperetti C, Tscherter A, Bernardi G, Maccarrone M, Calabresi P. Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biological Psychiatry. 57: 1583-9. PMID 15953496 DOI: 10.1016/J.Biopsych.2005.03.008 |
0.365 |
|
| 2005 |
Picconi B, Pisani A, Barone I, Bonsi P, Centonze D, Bernardi G, Calabresi P. Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. Neurotoxicology. 26: 779-83. PMID 15927256 DOI: 10.1016/J.Neuro.2005.02.002 |
0.361 |
|
| 2005 |
Centonze D, Gubellini P, Rossi S, Picconi B, Pisani A, Bernardi G, Calabresi P, Baunez C. Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. Neuroscience. 133: 831-40. PMID 15893432 DOI: 10.1016/J.Neuroscience.2005.03.006 |
0.329 |
|
| 2005 |
Pisani A, Centonze D, Bernardi G, Calabresi P. Striatal synaptic plasticity: implications for motor learning and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 395-402. PMID 15719415 DOI: 10.1002/Mds.20394 |
0.365 |
|
| 2005 |
Centonze D, Rossi S, Boffa L, Versace V, Palmieri MG, Caramia MD, Bernardi G. CSF from MS patients can induce acute conduction block in the isolated optic nerve. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 12: 45-8. PMID 15613146 DOI: 10.1111/J.1468-1331.2004.00946.X |
0.364 |
|
| 2004 |
Gubellini P, Pisani A, Centonze D, Bernardi G, Calabresi P. Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Progress in Neurobiology. 74: 271-300. PMID 15582223 DOI: 10.1016/J.Pneurobio.2004.09.005 |
0.394 |
|
| 2004 |
Centonze D, Gubellini P, Usiello A, Rossi S, Tscherter A, Bracci E, Erbs E, Tognazzi N, Bernardi G, Pisani A, Calabresi P, Borrelli E. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience. 129: 157-66. PMID 15489038 DOI: 10.1016/J.Neuroscience.2004.07.043 |
0.345 |
|
| 2004 |
Centonze D, Usiello A, Costa C, Picconi B, Erbs E, Bernardi G, Borrelli E, Calabresi P. Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 8214-22. PMID 15385604 DOI: 10.1523/Jneurosci.1274-04.2004 |
0.366 |
|
| 2004 |
Bracci E, Centonze D, Bernardi G, Calabresi P. Engagement of rat striatal neurons by cortical epileptiform activity investigated with paired recordings. Journal of Neurophysiology. 92: 2725-37. PMID 15240765 DOI: 10.1152/Jn.00585.2004 |
0.348 |
|
| 2004 |
Picconi B, Gardoni F, Centonze D, Mauceri D, Cenci MA, Bernardi G, Calabresi P, Di Luca M. Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5283-91. PMID 15190099 DOI: 10.1523/Jneurosci.1224-04.2004 |
0.358 |
|
| 2004 |
Picconi B, Centonze D, Rossi S, Bernardi G, Calabresi P. Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. Brain : a Journal of Neurology. 127: 1661-9. PMID 15155524 DOI: 10.1093/Brain/Awh190 |
0.35 |
|
| 2004 |
Gubellini P, Centonze D, Tropepi D, Bernardi G, Calabresi P. Induction of corticostriatal LTP by 3-nitropropionic acid requires the activation of mGluR1/PKC pathway. Neuropharmacology. 46: 761-9. PMID 15033336 DOI: 10.1016/J.Neuropharm.2003.11.021 |
0.347 |
|
| 2004 |
Napolitano M, Centonze D, Gubellini P, Rossi S, Spiezia S, Bernardi G, Gulino A, Calabresi P. Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease. Neurobiology of Disease. 15: 407-14. PMID 15006711 DOI: 10.1016/J.Nbd.2003.11.021 |
0.303 |
|
| 2004 |
Caramia MD, Palmieri MG, Desiato MT, Boffa L, Galizia P, Rossini PM, Centonze D, Bernardi G. Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 115: 956-65. PMID 15003779 DOI: 10.1016/J.Clinph.2003.11.024 |
0.414 |
|
| 2004 |
Saulle E, Gubellini P, Picconi B, Centonze D, Tropepi D, Pisani A, Morari M, Marti M, Rossi L, Papa M, Bernardi G, Calabresi P. Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. Molecular and Cellular Neurosciences. 25: 9-20. PMID 14962736 DOI: 10.1016/J.Mcn.2003.09.013 |
0.315 |
|
| 2003 |
Centonze D, Gubellini P, Pisani A, Bernardi G, Calabresi P. Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Reviews in the Neurosciences. 14: 207-16. PMID 14513864 DOI: 10.1515/Revneuro.2003.14.3.207 |
0.365 |
|
| 2003 |
Calabresi P, Centonze D, Pisani A, Cupini L, Bernardi G. Synaptic plasticity in the ischaemic brain. The Lancet. Neurology. 2: 622-9. PMID 14505584 DOI: 10.1016/S1474-4422(03)00532-5 |
0.342 |
|
| 2003 |
Calabresi P, Marti M, Picconi B, Saulle E, Costa C, Centonze D, Pisani F, Bernardi G. Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. Experimental Neurology. 182: 461-9. PMID 12895457 DOI: 10.1016/S0014-4886(03)00117-1 |
0.38 |
|
| 2003 |
Centonze D, Grande C, Usiello A, Gubellini P, Erbs E, Martin AB, Pisani A, Tognazzi N, Bernardi G, Moratalla R, Borrelli E, Calabresi P. Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6245-54. PMID 12867509 DOI: 10.1523/Jneurosci.23-15-06245.2003 |
0.314 |
|
| 2003 |
Pisani A, Bonsi P, Centonze D, Gubellini P, Bernardi G, Calabresi P. Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors. Neuropharmacology. 45: 45-56. PMID 12814658 DOI: 10.1016/S0028-3908(03)00137-0 |
0.357 |
|
| 2003 |
Maccarrone M, Gubellini P, Bari M, Picconi B, Battista N, Centonze D, Bernardi G, Finazzi-Agrò A, Calabresi P. Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. Journal of Neurochemistry. 85: 1018-25. PMID 12716433 DOI: 10.1046/J.1471-4159.2003.01759.X |
0.37 |
|
| 2003 |
Picconi B, Centonze D, HÃ¥kansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nature Neuroscience. 6: 501-6. PMID 12665799 DOI: 10.1038/Nn1040 |
0.344 |
|
| 2003 |
Calabresi P, Centonze D, Cupini LM, Costa C, Pisani F, Bernardi G. Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. Neurobiology of Disease. 12: 82-8. PMID 12609492 DOI: 10.1016/S0969-9961(02)00016-5 |
0.36 |
|
| 2003 |
Gubellini P, Saulle E, Centonze D, Costa C, Tropepi D, Bernardi G, Conquet F, Calabresi P. Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. Neuropharmacology. 44: 8-16. PMID 12559117 DOI: 10.1016/S0028-3908(02)00214-9 |
0.367 |
|
| 2003 |
Tofighy A, Abbott A, Centonze D, Cooper AJ, Noor E, Pearce SM, Puntis M, Stanford IM, Wigmore MA, Lacey MG. Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology. Neuroscience. 116: 157-66. PMID 12535949 DOI: 10.1016/S0306-4522(02)00546-8 |
0.318 |
|
| 2002 |
Saulle E, Centonze D, MartÃn AB, Moratalla R, Bernardi G, Calabresi P. Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors. Stroke; a Journal of Cerebral Circulation. 33: 2978-84. PMID 12468800 DOI: 10.1161/01.Str.0000038093.42512.0F |
0.361 |
|
| 2002 |
Centonze D, Usiello A, Gubellini P, Pisani A, Borrelli E, Bernardi G, Calabresi P. Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 723-6. PMID 12431847 DOI: 10.1016/S0893-133X(02)00367-6 |
0.313 |
|
| 2002 |
Picconi B, Pisani A, Centonze D, Battaglia G, Storto M, Nicoletti F, Bernardi G, Calabresi P. Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment. Brain : a Journal of Neurology. 125: 2635-45. PMID 12429591 DOI: 10.1093/Brain/Awf269 |
0.363 |
|
| 2002 |
Napolitano M, Centonze D, Calce A, Picconi B, Spiezia S, Gulino A, Bernardi G, Calabresi P. Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum. Neurobiology of Disease. 10: 387-95. PMID 12270699 DOI: 10.1006/Nbdi.2002.0525 |
0.321 |
|
| 2002 |
Centonze D, Napolitano M, Saulle E, Gubellini P, Picconi B, Martorana A, Pisani A, Gulino A, Bernardi G, Calabresi P. Tissue plasminogen activator is required for corticostriatal long-term potentiation. The European Journal of Neuroscience. 16: 713-21. PMID 12270047 DOI: 10.1046/J.1460-9568.2002.02106.X |
0.38 |
|
| 2002 |
Centonze D, Bracci E, Pisani A, Gubellini P, Bernardi G, Calabresi P. Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. The European Journal of Neuroscience. 15: 2049-52. PMID 12099911 DOI: 10.1046/J.1460-9568.2002.02052.X |
0.332 |
|
| 2002 |
Bracci E, Centonze D, Bernardi G, Calabresi P. Dopamine excites fast-spiking interneurons in the striatum. Journal of Neurophysiology. 87: 2190-4. PMID 11929936 DOI: 10.1152/Jn.00754.2001 |
0.333 |
|
| 2002 |
Centonze D, Saulle E, Pisani A, Bonsi P, Tropepi D, Bernardi G, Calabresi P. Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation. Neuroreport. 13: 115-8. PMID 11924871 DOI: 10.1097/00001756-200201210-00027 |
0.344 |
|
| 2002 |
Calabresi P, Saulle E, Centonze D, Pisani A, Marfia GA, Bernardi G. Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability. Brain : a Journal of Neurology. 125: 844-60. PMID 11912117 DOI: 10.1093/Brain/Awf073 |
0.352 |
|
| 2002 |
Centonze D, Picconi B, Baunez C, Borrelli E, Pisani A, Bernardi G, Calabresi P. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 164-75. PMID 11790512 DOI: 10.1016/S0893-133X(01)00299-8 |
0.348 |
|
| 2002 |
Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, Bernardi G, Finazzi-Agrò A, Maccarrone M. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. The Journal of Neuroscience. 22: 6900-6907. DOI: 10.1523/Jneurosci.22-16-06900.2002 |
0.345 |
|
| 2002 |
Pisani A, Bonsi P, Catania MV, Giuffrida R, Morari M, Marti M, Centonze D, Bernardi G, Kingston AE, Calabresi P. Metabotropic Glutamate 2 Receptors Modulate Synaptic Inputs and Calcium Signals in Striatal Cholinergic Interneurons The Journal of Neuroscience. 22: 6176-6185. DOI: 10.1523/Jneurosci.22-14-06176.2002 |
0.365 |
|
| 2001 |
Centonze D, Gubellini P, Bernardi G, Calabresi P. Impaired excitatory transmission in the striatum of rats chronically intoxicated with manganese. Experimental Neurology. 172: 469-76. PMID 11716571 DOI: 10.1006/Exnr.2001.7812 |
0.397 |
|
| 2001 |
Pisani A, Gubellini P, Bonsi P, Conquet F, Picconi B, Centonze D, Bernardi G, Calabresi P. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience. 106: 579-87. PMID 11591458 DOI: 10.1016/S0306-4522(01)00297-4 |
0.347 |
|
| 2001 |
Centonze D, Saulle E, Pisani A, Bernardi G, Calabresi P. Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia. Brain : a Journal of Neurology. 124: 1855-65. PMID 11522587 DOI: 10.1093/Brain/124.9.1855 |
0.374 |
|
| 2001 |
Centonze D, Gubellini P, Picconi B, Saulle E, Tolu M, Bonsi P, Giacomini P, Calabresi P. An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 22: 61-2. PMID 11487202 DOI: 10.1007/S100720170047 |
0.391 |
|
| 2001 |
Calabresi P, Ammassari-Teule M, Gubellini P, Sancesario G, Morello M, Centonze D, Marfia GA, Saulle E, Passino E, Picconi B, Bernardi G. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. Neurobiology of Disease. 8: 419-32. PMID 11442351 DOI: 10.1006/Nbdi.2000.0379 |
0.377 |
|
| 2001 |
Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P, Greengard P, Hipskind RA, Borrelli E, Bernardi G. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 5110-20. PMID 11438586 DOI: 10.1523/Jneurosci.21-14-05110.2001 |
0.386 |
|
| 2001 |
Battaglia G, Bruno V, Pisani A, Centonze D, Catania MV, Calabresi P, Nicoletti F. Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. Molecular and Cellular Neurosciences. 17: 1071-83. PMID 11414795 DOI: 10.1006/Mcne.2001.0992 |
0.336 |
|
| 2001 |
Gubellini P, Saulle E, Centonze D, Bonsi P, Pisani A, Bernardi G, Conquet F, Calabresi P. Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharmacology. 40: 839-46. PMID 11378154 DOI: 10.1016/S0028-3908(01)00021-1 |
0.401 |
|
| 2001 |
Centonze D, Picconi B, Gubellini P, Bernardi G, Calabresi P. Dopaminergic control of synaptic plasticity in the dorsal striatum. The European Journal of Neuroscience. 13: 1071-7. PMID 11285003 DOI: 10.1046/J.0953-816X.2001.01485.X |
0.385 |
|
| 2001 |
Pisani A, Bonsi P, Centonze D, Bernardi G, Calabresi P. Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons. Neuropharmacology. 40: 460-3. PMID 11166340 DOI: 10.1016/S0028-3908(00)00184-2 |
0.345 |
|
| 2001 |
Centonze D, Pisani A, Bonsi P, Giacomini P, Bernardi G, Calabresi P. Stimulation of Nitric Oxide–cGMP Pathway Excites Striatal Cholinergic Interneurons via Protein Kinase G Activation The Journal of Neuroscience. 21: 1393-1400. DOI: 10.1523/Jneurosci.21-04-01393.2001 |
0.324 |
|
| 2000 |
Calabresi P, Centonze D, Bernardi G. Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum. Neurology. 55: 1249-55. PMID 11092223 DOI: 10.1212/Wnl.55.9.1249 |
0.36 |
|
| 2000 |
Calabresi P, Gubellini P, Centonze D, Picconi B, Bernardi G, Chergui K, Svenningsson P, Fienberg AA, Greengard P. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8443-51. PMID 11069952 DOI: 10.1523/Jneurosci.20-22-08443.2000 |
0.347 |
|
| 2000 |
Calabresi P, Centonze D, Bernardi G. Electrophysiology of dopamine in normal and denervated striatal neurons. Trends in Neurosciences. 23: S57-63. PMID 11052221 DOI: 10.1016/S1471-1931(00)00017-3 |
0.32 |
|
| 2000 |
Pisani A, Bernardi G, Bonsi P, Centonze D, Giacomini P, Calabresi P. Cell-type specificity of mGluR activation in striatal neuronal subtypes. Amino Acids. 19: 119-29. PMID 11026480 DOI: 10.1007/S007260070040 |
0.348 |
|
| 2000 |
Calabresi P, Napolitano M, Centonze D, Marfia GA, Gubellini P, Teule MA, Berretta N, Bernardi G, Frati L, Tolu M, Gulino A. Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. The European Journal of Neuroscience. 12: 1002-12. PMID 10762331 DOI: 10.1046/J.1460-9568.2000.00991.X |
0.327 |
|
| 2000 |
Calabresi P, Centonze D, Gubellini P, Marfia GA, Pisani A, Sancesario G, Bernardi G. Synaptic transmission in the striatum: from plasticity to neurodegeneration. Progress in Neurobiology. 61: 231-65. PMID 10727775 DOI: 10.1016/S0301-0082(99)00030-1 |
0.39 |
|
| 2000 |
Calabresi P, Stefani A, Marfia GA, Hainsworth AH, Centonze D, Saulle E, Spadoni F, Leach MJ, Giacomini P, Bernardi G. Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects. Experimental Neurology. 162: 171-9. PMID 10716897 DOI: 10.1006/Exnr.2000.7285 |
0.322 |
|
| 2000 |
Calabresi P, Picconi B, Saulle E, Centonze D, Hainsworth AH, Bernardi G. Is pharmacological neuroprotection dependent on reduced glutamate release? Stroke; a Journal of Cerebral Circulation. 31: 766-72; discussion 7. PMID 10700517 DOI: 10.1161/01.Str.31.3.766 |
0.359 |
|
| 2000 |
Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G. Acetylcholine-mediated modulation of striatal function. Trends in Neurosciences. 23: 120-6. PMID 10675916 DOI: 10.1016/S0166-2236(99)01501-5 |
0.359 |
|
| 2000 |
Pisani A, Bonsi P, Centonze D, Calabresi P, Bernardi G. Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. The Journal of Neuroscience. 20. DOI: 10.1523/Jneurosci.20-07-J0003.2000 |
0.384 |
|
| 1999 |
Centonze D, Calabresi P, Giacomini P, Bernardi G. Neurophysiology of Parkinson's disease: from basic research to clinical correlates. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 110: 2006-13. PMID 10616104 DOI: 10.1016/S1388-2457(99)00173-X |
0.348 |
|
| 1999 |
Centonze D, Gubellini P, Bernardi G, Calabresi P. Permissive role of interneurons in corticostriatal synaptic plasticity. Brain Research. Brain Research Reviews. 31: 1-5. PMID 10611492 DOI: 10.1016/S0165-0173(99)00018-1 |
0.374 |
|
| 1999 |
Centonze D, Gubellini P, Picconi B, Calabresi P, Giacomini P, Bernardi G. Unilateral dopamine denervation blocks corticostriatal LTP. Journal of Neurophysiology. 82: 3575-9. PMID 10601483 DOI: 10.1152/Jn.1999.82.6.3575 |
0.361 |
|
| 1999 |
Napolitano M, Marfia GA, Vacca A, Centonze D, Bellavia D, Di Marcotullio L, Frati L, Bernardi G, Gulino A, Calabresi P. Modulation of gene expression following long-term synaptic depression in the striatum. Brain Research. Molecular Brain Research. 72: 89-96. PMID 10521602 DOI: 10.1016/S0169-328X(99)00213-2 |
0.309 |
|
| 1999 |
Calabresi P, Centonze D, Pisani A, Bernardi G. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease. Experimental Neurology. 158: 97-108. PMID 10448421 DOI: 10.1006/Exnr.1999.7092 |
0.378 |
|
| 1999 |
Calabresi P, Centonze D, Gubellini P, Bernardi G. Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. Neuropharmacology. 38: 323-6. PMID 10218876 DOI: 10.1016/S0028-3908(98)00199-3 |
0.328 |
|
| 1999 |
Calabresi P, Centonze D, Marfia GA, Pisani A, Bernardi G. An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons. British Journal of Pharmacology. 126: 689-96. PMID 10188980 DOI: 10.1038/Sj.Bjp.0702361 |
0.371 |
|
| 1999 |
Calabresi P, Centonze D, Gubellini P, Marfia GA, Bernardi G. Glutamate-triggered events inducing corticostriatal long-term depression. The Journal of Neuroscience. 19: 6102-6110. DOI: 10.1523/Jneurosci.19-14-06102.1999 |
0.388 |
|
| 1999 |
Calabresi P, Gubellini P, Centonze D, Sancesario G, Morello M, Giorgi M, Pisani A, Bernardi G. A Critical Role of the Nitric Oxide/cGMP Pathway in Corticostriatal Long-Term Depression The Journal of Neuroscience. 19: 2489-2499. DOI: 10.1523/Jneurosci.19-07-02489.1999 |
0.332 |
|
| 1998 |
Centonze D, Calabresi P, Pisani A, Marinelli S, Marfia GA, Bernardi G. Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons. Neuropharmacology. 37: 1063-70. PMID 9833635 DOI: 10.1016/S0028-3908(98)00081-1 |
0.353 |
|
| 1998 |
Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G. Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses. The European Journal of Neuroscience. 10: 3020-3. PMID 9758172 DOI: 10.1111/J.1460-9568.1998.00348.X |
0.369 |
|
| 1998 |
Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G. Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation. The European Journal of Neuroscience. 10: 2887-95. PMID 9758158 DOI: 10.1111/J.1460-9568.1998.00294.X |
0.347 |
|
| 1998 |
Calabresi P, Centonze D, Pisani A, Sancesario G, North RA, Bernardi G. Muscarinic IPSPs in rat striatal cholinergic interneurones. The Journal of Physiology. 510: 421-7. PMID 9705993 DOI: 10.1111/J.1469-7793.1998.421Bk.X |
0.33 |
|
| 1998 |
Calabresi P, Centonze D, Pisani A, Sancesario G, Gubellini P, Marfia GA, Bernardi G. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease. Annals of Neurology. 43: 586-97. PMID 9585352 DOI: 10.1002/Ana.410430506 |
0.362 |
|
| 1997 |
Calabresi P, Centonze D, Pisani A, Bernardi G. A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 1121-6. PMID 9346437 DOI: 10.1097/00004647-199710000-00014 |
0.328 |
|
| 1997 |
Pisani A, Calabresi P, Centonze D, Bernardi G. Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse. Neuropharmacology. 36: 845-51. PMID 9225312 DOI: 10.1016/S0028-3908(96)00177-3 |
0.327 |
|
| 1997 |
Calabresi P, Pisani A, Centonze D, Bernardi G. Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum. Neuroscience and Biobehavioral Reviews. 21: 519-23. PMID 9195611 DOI: 10.1016/S0149-7634(96)00029-2 |
0.357 |
|
| 1997 |
Pisani A, Calabresi P, Centonze D, Bernardi G. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones. British Journal of Pharmacology. 120: 1007-14. PMID 9134210 DOI: 10.1038/Sj.Bjp.0700999 |
0.318 |
|
| 1997 |
Calabresi P, Saiardi A, Pisani A, Baik JH, Centonze D, Mercuri NB, Bernardi G, Borrelli E. Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors The Journal of Neuroscience. 17: 4536-4544. DOI: 10.1523/Jneurosci.17-12-04536.1997 |
0.384 |
|
| 1997 |
Calabresi P, Centonze D, Pisani A, Bernardi G. Endogenous Adenosine Mediates the Presynaptic Inhibition Induced by Aglycemia at Corticostriatal Synapses The Journal of Neuroscience. 17: 4509-4516. DOI: 10.1523/Jneurosci.17-12-04509.1997 |
0.368 |
|
| 1997 |
Calabresi P, Ascone CM, Centonze D, Pisani A, Sancesario G, D’Angelo V, Bernardi G. Opposite Membrane Potential Changes Induced by Glucose Deprivation in Striatal Spiny Neurons and in Large Aspiny Interneurons The Journal of Neuroscience. 17: 1940-1949. DOI: 10.1523/Jneurosci.17-06-01940.1997 |
0.307 |
|
| 1996 |
Calabresi P, Pisani A, Centonze D, Stefani A, Bernardi G, Lucia OS. Role of mGluRs in the modulation of synaptic activity of different striatal neuronal subtypes Neuropharmacology. 35: A7. DOI: 10.1016/0028-3908(96)84675-2 |
0.347 |
|
| 1996 |
Calabresi P, Pisani A, Centonze D, Bernardi G. Role of Ca2+in striatal LTD and LTP Seminars in Neuroscience. 8: 321-328. DOI: 10.1006/Smns.1996.0039 |
0.334 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2007 |
Centonze D, Rossi S, De Chiara V, Prosperetti C, Battista N, Bernardi G, Mercuri NB, Usiello A, Maccarrone M. Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors. The European Journal of Neuroscience. 25: 1631-40. PMID 17408430 DOI: 10.1111/J.1460-9568.2007.05433.X |
0.299 |
|
| 2010 |
Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S, Martella G, Nisticò R, Centonze D, Pisani A, Gu HH, Mercuri NB, Usiello A. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 11043-56. PMID 20720111 DOI: 10.1523/Jneurosci.1682-10.2010 |
0.299 |
|
| 2015 |
Stüve O, Centonze D. Treatment decisions for patients with active multiple sclerosis. Jama Neurology. 72: 387-9. PMID 25664937 DOI: 10.1001/Jamaneurol.2014.4494 |
0.299 |
|
| 2010 |
De Chiara V, Angelucci F, Rossi S, Musella A, Cavasinni F, Cantarella C, Mataluni G, Sacchetti L, Napolitano F, Castelli M, Caltagirone C, Bernardi G, Maccarrone M, Usiello A, Centonze D. Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 8127-37. PMID 20554863 DOI: 10.1523/Jneurosci.1683-10.2010 |
0.298 |
|
| 2019 |
Stampanoni Bassi M, Iezzi E, Gilio L, Centonze D, Buttari F. Synaptic Plasticity Shapes Brain Connectivity: Implications for Network Topology. International Journal of Molecular Sciences. 20. PMID 31817968 DOI: 10.3390/Ijms20246193 |
0.298 |
|
| 2015 |
Mechelli R, Manzari C, Policano C, Annese A, Picardi E, Umeton R, Fornasiero A, D'Erchia AM, Buscarinu MC, Agliardi C, Annibali V, Serafini B, Rosicarelli B, Romano S, Angelini DF, ... ... Centonze D, et al. Epstein-Barr virus genetic variants are associated with multiple sclerosis. Neurology. 84: 1362-8. PMID 25740864 DOI: 10.1212/Wnl.0000000000001420 |
0.297 |
|
| 2011 |
Ribolsi M, Mori F, Magni V, Codecà C, Kusayanagi H, Monteleone F, Rubino IA, Siracusano A, Bernardi G, Centonze D, Koch G. Impaired inter-hemispheric facilitatory connectivity in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 122: 512-7. PMID 20864396 DOI: 10.1016/J.Clinph.2010.08.013 |
0.296 |
|
| 2014 |
Centonze D. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. European Neurology. 72: 6-8. PMID 25278116 DOI: 10.1159/000367615 |
0.296 |
|
| 2016 |
Bargagli AM, Colais P, Agabiti N, Mayer F, Buttari F, Centonze D, Di Folco M, Filippini G, Francia A, Galgani S, Gasperini C, Giuliani M, Mirabella M, Nociti V, Pozzilli C, et al. Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems. Journal of Neurology. PMID 26886201 DOI: 10.1007/S00415-016-8049-8 |
0.296 |
|
| 2015 |
Rossi S, Rocchi C, Studer V, Motta C, Lauretti B, Germani G, Macchiarulo G, Marfia GA, Centonze D. The autonomic balance predicts cardiac responses after the first dose of fingolimod. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 206-16. PMID 24957049 DOI: 10.1177/1352458514538885 |
0.296 |
|
| 2014 |
Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Gallo A, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, et al. Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group Neurological Sciences. 35: 1645-1646. DOI: 10.1007/S10072-014-1649-0 |
0.296 |
|
| 2018 |
Stampanoni Bassi M, Gilio L, Maffei P, Dolcetti E, Bruno A, Buttari F, Centonze D, Iezzi E. Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression. Frontiers in Molecular Neuroscience. 11: 424. PMID 30515077 DOI: 10.3389/Fnmol.2018.00424 |
0.295 |
|
| 2016 |
Halper J, Centonze D, Newsome SD, Huang D, Robertson C, You X, Sabatella G, Evilevitch V, Leahy L. Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a: Obtaining Recommendations Using the Delphi Technique. International Journal of Ms Care. 18: 211-8. PMID 27551246 DOI: 10.7224/1537-2073.2015-042 |
0.295 |
|
| 2012 |
Butti E, Bacigaluppi M, Rossi S, Cambiaghi M, Bari M, Cebrian Silla A, Brambilla E, Musella A, De Ceglia R, Teneud L, De Chiara V, D'Adamo P, Garcia-Verdugo JM, Comi G, Muzio L, ... ... Centonze D, et al. Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity. Brain : a Journal of Neurology. 135: 3320-35. PMID 23008234 DOI: 10.1093/Brain/Aws194 |
0.295 |
|
| 2008 |
Errico F, Rossi S, Napolitano F, Catuogno V, Topo E, Fisone G, D'Aniello A, Centonze D, Usiello A. D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 10404-14. PMID 18842900 DOI: 10.1523/Jneurosci.1618-08.2008 |
0.294 |
|
| 2019 |
Prosperini L, Cortese A, Lucchini M, Boffa L, Borriello G, Buscarinu MC, Capone F, Centonze D, De Fino C, De Pascalis D, Fantozzi R, Ferraro E, Filippi M, Galgani S, Gasperini C, et al. Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study. Journal of Neurology. PMID 31720848 DOI: 10.1007/S00415-019-09625-1 |
0.293 |
|
| 2017 |
Buttari F, Zagaglia S, Marciano L, Albanese M, Landi D, Nicoletti CG, Mercuri NB, Silvestrini M, Provinciali L, Marfia GA, Mori F, Centonze D. TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis. Journal of Neuroimmunology. 305: 172-174. PMID 28284340 DOI: 10.1016/J.Jneuroim.2017.02.007 |
0.293 |
|
| 2004 |
Centonze D, Battista N, Rossi S, Mercuri NB, Finazzi-Agrò A, Bernardi G, Calabresi P, Maccarrone M. A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1488-97. PMID 15100701 DOI: 10.1038/Sj.Npp.1300458 |
0.293 |
|
| 2009 |
Errico F, Napolitano F, Nisticò R, Centonze D, Usiello A. D-aspartate: an atypical amino acid with neuromodulatory activity in mammals. Reviews in the Neurosciences. 20: 429-40. PMID 20397623 DOI: 10.1515/Revneuro.2009.20.5-6.429 |
0.292 |
|
| 2020 |
Sørensen PS, Centonze D, Giovannoni G, Montalban X, Selchen D, Vermersch P, Wiendl H, Yamout B, Salloukh H, Rieckmann P. Expert Opinion on the Use of Cladribine Tablets in Clinical Practice for the Treatment of Relapsing Multiple Sclerosis Multiple Sclerosis and Related Disorders. 37: 101584. DOI: 10.1016/J.Msard.2019.11.059 |
0.291 |
|
| 2006 |
Napolitano M, Picconi B, Centonze D, Bernardi G, Calabresi P, Gulino A. L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases. Neuroscience Letters. 398: 211-4. PMID 16529858 DOI: 10.1016/J.Neulet.2005.12.077 |
0.291 |
|
| 2004 |
Centonze D, Siracusano A, Calabresi P, Bernardi G. The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory. Brain Research. Brain Research Reviews. 46: 310-4. PMID 15571772 DOI: 10.1016/J.Brainresrev.2004.07.006 |
0.291 |
|
| 2010 |
Mori F, Codecà C, Kusayanagi H, Monteleone F, Buttari F, Fiore S, Bernardi G, Koch G, Centonze D. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. The Journal of Pain : Official Journal of the American Pain Society. 11: 436-42. PMID 20018567 DOI: 10.1016/J.Jpain.2009.08.011 |
0.291 |
|
| 2017 |
Centonze D, Iannazzo S, Santoni L, Saleri C, Puma E, Giuliani L, Canonico PL. The economic profile of peginterferon beta-1a in the treatment of relapsing-remitting multiple sclerosis in Italy Multiple Sclerosis and Demyelinating Disorders. 2. DOI: 10.1186/S40893-017-0030-6 |
0.291 |
|
| 2010 |
D'Aguanno S, Franciotta D, Lupisella S, Barassi A, Pieragostino D, Lugaresi A, Centonze D, D'Eril GM, Bernardini S, Federici G, Urbani A. Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry. Neuroscience Letters. 485: 49-54. PMID 20801190 DOI: 10.1016/J.Neulet.2010.08.060 |
0.289 |
|
| 2016 |
Bacigaluppi M, Russo GL, Peruzzotti-Jametti L, Rossi S, Sandrone S, Butti E, De Ceglia R, Bergamaschi A, Motta C, Gallizioli M, Studer V, Colombo E, Farina C, Comi G, Politi LS, ... ... Centonze D, et al. Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 10529-10544. PMID 27733606 DOI: 10.1523/Jneurosci.1643-16.2016 |
0.288 |
|
| 2019 |
Olivola E, Fasano A, Varanese S, Lena F, Santilli M, Femiano C, Centonze D, Modugno N. Continuous subcutaneous apomorphine infusion in Parkinson's disease: causes of discontinuation and subsequent treatment strategies. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 31111272 DOI: 10.1007/S10072-019-03920-5 |
0.288 |
|
| 2016 |
Prosperini L, Saccà F, Cordioli C, Cortese A, Buttari F, Pontecorvo S, Bianco A, Ruggieri S, Haggiag S, Brescia Morra V, Capra R, Centonze D, Di Battista G, Ferraro E, Francia A, et al. Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis. Journal of Neurology. PMID 27878443 DOI: 10.1007/S00415-016-8343-5 |
0.288 |
|
| 2011 |
Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Picconi O, Cilia S, Cottone S, Centonze D, Gasperini C. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 991-1001. PMID 21502310 DOI: 10.1177/1352458511401943 |
0.288 |
|
| 2011 |
Mori F, Rossi S, Bergami A, Kusayanagi H, Mancino R, Martino G, Furlan R, Centonze D. P18.4 IL-13, neuroprotection and cortical excitability in multiple sclerosis Clinical Neurophysiology. 122: S138-S139. DOI: 10.1016/S1388-2457(11)60494-X |
0.287 |
|
| 1998 |
Pedersen JZ, Bernardi G, Centonze D, Pisani A, Rossi L, Rotilio G, Calabresi P. Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 868-75. PMID 9701347 DOI: 10.1097/00004647-199808000-00006 |
0.286 |
|
| 2012 |
Mori F, Ribolsi M, Kusayanagi H, Monteleone F, Mantovani V, Buttari F, Marasco E, Bernardi G, Maccarrone M, Centonze D. TRPV1 channels regulate cortical excitability in humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 873-9. PMID 22262885 DOI: 10.1523/Jneurosci.2531-11.2012 |
0.285 |
|
| 2018 |
Mirabella M, Prosperini L, Lucchini M, Boffa L, Borriello G, Buscarinu MC, Centonze D, Cortese A, De Fino C, De Giglio L, Elia G, Fantozzi R, Ferraro E, Francia A, Galgani S, et al. Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study. Cns Drugs. PMID 30022464 DOI: 10.1007/S40263-018-0543-3 |
0.285 |
|
| 2018 |
Solaro C, Cella M, Signori A, Martinelli V, Radaelli M, Centonze D, Sica F, Grasso MG, Clemenzi A, Bonavita S, Esposito S, Patti F, D'Amico E, Cruccu G, Truini A, et al. Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria. Journal of Neurology. PMID 29404736 DOI: 10.1007/S00415-018-8758-2 |
0.283 |
|
| 1999 |
Calabresi P, Marfia GA, Centonze D, Pisani A, Bernardi G. Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons. Stroke; a Journal of Cerebral Circulation. 30: 171-9. PMID 9880406 DOI: 10.1161/01.Str.30.1.171 |
0.282 |
|
| 2009 |
Ammatuna E, Montefusco E, Pacilli M, Divona M, Ardiri D, Centonze D, Lo-Coco F. Use of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone. Leukemia & Lymphoma. 50: 1217-8. PMID 19479616 DOI: 10.1080/10428190902912486 |
0.281 |
|
| 2020 |
Dolcetti E, Bruno A, Guadalupi L, Rizzo FR, Musella A, Gentile A, De Vito F, Caioli S, Bullitta S, Fresegna D, Vanni V, Balletta S, Sanna K, Buttari F, Stampanoni Bassi M, ... Centonze D, et al. Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis. International Journal of Molecular Sciences. 21. PMID 33020408 DOI: 10.3390/ijms21197336 |
0.28 |
|
| 2003 |
Bracci E, Centonze D, Bernardi G, Calabresi P. Voltage-dependent membrane potential oscillations of rat striatal fast-spiking interneurons. The Journal of Physiology. 549: 121-30. PMID 12665602 DOI: 10.1113/Jphysiol.2003.040857 |
0.278 |
|
| 2022 |
Filippi M, Amato MP, Centonze D, Gallo P, Gasperini C, Inglese M, Patti F, Pozzilli C, Preziosa P, Trojano M. Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion. Journal of Neurology. PMID 35608658 DOI: 10.1007/s00415-022-11193-w |
0.278 |
|
| 2003 |
Calabresi P, Cupini LM, Centonze D, Pisani F, Bernardi G. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Annals of Neurology. 53: 693-702. PMID 12783414 DOI: 10.1002/Ana.10603 |
0.277 |
|
| 2015 |
Bertoli D, Serana F, Sottini A, Cordioli C, Maimone D, Amato MP, Centonze D, Florio C, Puma E, Capra R, Imberti L. Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene. Plos One. 10: e0135441. PMID 26285213 DOI: 10.1371/Journal.Pone.0135441 |
0.277 |
|
| 2012 |
Oddi S, Dainese E, Sandiford S, Fezza F, Lanuti M, Chiurchiù V, Totaro A, Catanzaro G, Barcaroli D, De Laurenzi V, Centonze D, Mukhopadhyay S, Selent J, Howlett AC, Maccarrone M. Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling. British Journal of Pharmacology. 165: 2635-51. PMID 21895628 DOI: 10.1111/J.1476-5381.2011.01658.X |
0.277 |
|
| 2000 |
Calabresi P, Giacomini P, Centonze D, Bernardi G. Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? Annals of Neurology. 47: S60-8; discussion S6. PMID 10762133 |
0.276 |
|
| 2020 |
Fresegna D, Bullitta S, Musella A, Rizzo FR, De Vito F, Guadalupi L, Caioli S, Balletta S, Sanna K, Dolcetti E, Vanni V, Bruno A, Buttari F, Stampanoni Bassi M, Mandolesi G, ... Centonze D, et al. Re-Examining the Role of TNF in MS Pathogenesis and Therapy. Cells. 9. PMID 33066433 DOI: 10.3390/cells9102290 |
0.276 |
|
| 2012 |
Saraceno R, Faleri S, Ruzzetti M, Centonze D, Chimenti S. Prevalence and management of panic attacks during infliximab infusion in psoriatic patients. Dermatology (Basel, Switzerland). 225: 236-41. PMID 23183380 DOI: 10.1159/000343609 |
0.276 |
|
| 2016 |
Solaro C, Trabucco E, Signori A, Martinelli V, Radaelli M, Centonze D, Rossi S, Grasso MG, Clemenzi A, Bonavita S, D'Ambrosio A, Patti F, D'Amico E, Cruccu G, Truini A. Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory. Plos One. 11: e0160261. PMID 27632167 DOI: 10.1371/Journal.Pone.0160261 |
0.276 |
|
| 2012 |
Filomeni G, Graziani I, De Zio D, Dini L, Centonze D, Rotilio G, Ciriolo MR. Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease. Neurobiology of Aging. 33: 767-85. PMID 20594614 DOI: 10.1016/J.Neurobiolaging.2010.05.021 |
0.274 |
|
| 2016 |
Centonze D, Puma E, Saleri C, Vestri G, Iannazzo S, Santoni L, Giuliani L, Canonico PL. [Pegylation and interferons in multiple sclerosis] Farmeconomia. Health Economics and Therapeutic Pathways. 17: 5-11. DOI: 10.7175/Fe.V17I2S.1229 |
0.273 |
|
| 2001 |
Centonze D, Marfia GA, Pisani A, Picconi B, Giacomini P, Bernardi G, Calabresi P. Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons. Progress in Neurobiology. 63: 687-96. PMID 11165001 DOI: 10.1016/S0301-0082(00)00037-X |
0.273 |
|
| 2021 |
Stampanoni Bassi M, Gilio L, Iezzi E, Moscatelli A, Pekmezovic T, Drulovic J, Furlan R, Finardi A, Mandolesi G, Musella A, Galifi G, Fantozzi R, Bellantonio P, Storto M, Centonze D, et al. Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis. Frontiers in Aging Neuroscience. 13: 694651. PMID 34566620 DOI: 10.3389/fnagi.2021.694651 |
0.272 |
|
| 2018 |
Etoom M, Khraiwesh Y, Lena F, Hawamdeh M, Hawamdeh Z, Centonze D, Foti C. Effectiveness of Physiotherapy Interventions on Spasticity in People with Multiple Sclerosis. A Systematic Review and Meta-Analysis. American Journal of Physical Medicine & Rehabilitation. PMID 29794531 DOI: 10.1097/Phm.0000000000000970 |
0.272 |
|
| 2019 |
Solari A, Giovannetti AM, Giordano A, Tortorella C, Torri Clerici V, Brichetto G, Granella F, Lugaresi A, Patti F, Salvetti M, Pesci I, Pucci E, Centonze D, Danni MC, Bonavita S, et al. Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany. Frontiers in Neurology. 10: 916. PMID 31507519 DOI: 10.3389/Fneur.2019.00916 |
0.271 |
|
| 2018 |
Romigi A, Vitrani G, Lo Giudice T, Centonze D, Franco V. Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy. Drug Design, Development and Therapy. 12: 2665-2675. PMID 30214155 DOI: 10.2147/Dddt.S101145 |
0.271 |
|
| 2020 |
Romigi A, Bari M, Liguori C, Izzi F, Rapino C, Nuccetelli M, Battista N, Bernardini S, Centonze D, Mercuri N, Placidi F, Maccarrone M. CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study. Cns & Neurological Disorders Drug Targets. PMID 32148204 DOI: 10.2174/1871527319666200309115602 |
0.27 |
|
| 2009 |
D'Argenzio L, Koch G, Bombardieri R, Mori F, Moavero R, Centonze D, Curatolo P. P130 Abnormal parieto-motor connectivity in tuberous sclerosis complex European Journal of Paediatric Neurology. 13. DOI: 10.1016/S1090-3798(09)70188-6 |
0.269 |
|
| 2016 |
Lugaresi A, De Robertis F, Clerico M, Brescia Morra V, Centonze D, Borghesan S, Maniscalco GT, On Behalf Of The River Study Group. Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study. Expert Opinion On Drug Delivery. 1-5. PMID 26909646 DOI: 10.1517/17425247.2016.1148029 |
0.268 |
|
| 1999 |
Calabresi P, Centonze D, Gubellini P, Marfia GA, Bernardi G. Glutamate-triggered events inducing corticostriatal long-term depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 6102-10. PMID 10407046 |
0.268 |
|
| 2013 |
Laricchiuta D, Centonze D, Petrosini L. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction. Behavioural Brain Research. 256: 101-7. PMID 23948212 DOI: 10.1016/J.Bbr.2013.08.010 |
0.268 |
|
| 2018 |
Centonze D, Iannazzo S, Santoni L, Saleri C, Puma E, Giuliani L, Canonico PL. Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis Farmeconomia. Health Economics and Therapeutic Pathways. 19. DOI: 10.7175/Fe.V19I1.1385 |
0.267 |
|
| 1996 |
Pisani A, Calabresi P, Centonze D, Stefani A, Bernardi G, Lucia OS. Group I mGluRs enhance NMDA responses in the striatum Neuropharmacology. 35: A24. DOI: 10.1016/0028-3908(96)84740-X |
0.267 |
|
| 2008 |
Koch G, Ribolsi M, Mori F, Sacchetti L, Codecà C, Rubino IA, Siracusano A, Bernardi G, Centonze D. Connectivity between posterior parietal cortex and ipsilateral motor cortex is altered in schizophrenia. Biological Psychiatry. 64: 815-9. PMID 18632089 DOI: 10.1016/J.Biopsych.2008.05.026 |
0.266 |
|
| 1997 |
Calabresi P, Saiardi A, Pisani A, Baik JH, Centonze D, Mercuri NB, Bernardi G, Borrelli E. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4536-44. PMID 9169514 |
0.266 |
|
| 2023 |
Baione V, Canevelli M, Belvisi D, Buscarinu MC, Bellucci G, Fantozzi R, Nicoletti CG, Malatuni G, Cortese A, De Giglio L, Tartaglia M, Ferrazzano G, Malimpensa L, Leodori G, Bruno G, ... ... Centonze D, et al. Frailty and relapse activity in multiple sclerosis: A longitudinal observation. Multiple Sclerosis and Related Disorders. 72: 104603. PMID 36905818 DOI: 10.1016/j.msard.2023.104603 |
0.265 |
|
| 2017 |
Lena F, Iezzi E, Etoom M, Santilli M, Centonze D, Foti C, Grillea G, Modugno N. Effects of postural exercises in patients with Parkinson's disease and Pisa syndrome: A pilot study. Neurorehabilitation. PMID 28946570 DOI: 10.3233/Nre-162033 |
0.265 |
|
| 2004 |
Bonsi P, Calabresi P, De Persis C, Papa M, Centonze D, Bernardi G, Pisani A. Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons. Experimental Neurology. 185: 169-81. PMID 14697328 DOI: 10.1016/J.Expneurol.2003.09.016 |
0.264 |
|
| 2007 |
Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rötzschke O, Falk K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 110: 1225-32. PMID 17449799 DOI: 10.1182/Blood-2006-12-064527 |
0.264 |
|
| 2000 |
Pisani A, Bonsi P, Centonze D, Calabresi P, Bernardi G. Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: RC69. PMID 10729358 |
0.264 |
|
| 2012 |
Lugaresi A, Florio C, Brescia-Morra V, Cottone S, Bellantonio P, Clerico M, Centonze D, Uccelli A, di Ioia M, De Luca G, Marcellusi A, Paolillo A. Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study. Bmc Neurology. 12: 7. PMID 22390218 DOI: 10.1186/1471-2377-12-7 |
0.264 |
|
| 2004 |
Calabresi P, Costa C, Centonze D, Pisani A, Bernardi G. The Concept of “Neuroprotection” in Neurological Diseases Current Neuropharmacology. 2: 261-263. DOI: 10.2174/1570159043359701 |
0.261 |
|
| 2009 |
Fazio R, Malosio ML, Lampasona V, De Feo D, Privitera D, Marnetto F, Centonze D, Ghezzi A, Comi G, Furlan R, Martino G. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 1153-63. PMID 19667009 DOI: 10.1177/1352458509106851 |
0.261 |
|
| 2008 |
D'Argenzio L, Moavero R, Koch G, Codecà C, Compagnone E, Pinci M, Bombardieri R, Centonze D, Curatolo P. Paired transcranial magnetic stimulation in tuberous sclerosis complex European Journal of Paediatric Neurology. 12: S27. DOI: 10.1016/S1090-3798(08)70084-9 |
0.261 |
|
| 2020 |
Etoom M, Alwardat M, Aburub AS, Lena F, Fabbrizo R, Modugno N, Centonze D. Therapeutic interventions for Pisa syndrome in idiopathic Parkinson's disease. A Scoping Systematic Review. Clinical Neurology and Neurosurgery. 198: 106242. PMID 32979681 DOI: 10.1016/J.Clineuro.2020.106242 |
0.26 |
|
| 2013 |
Duranti F, Pieri M, Centonze D, Buttari F, Bernardini S, Dessi M. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis. Journal of Neuroimmunology. 263: 116-20. PMID 23916392 DOI: 10.1016/J.Jneuroim.2013.07.006 |
0.26 |
|
| 2020 |
Stampanoni Bassi M, Buttari F, Nicoletti CG, Mori F, Gilio L, Simonelli I, De Paolis N, Marfia GA, Furlan R, Finardi A, Centonze D, Iezzi E. Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis. International Journal of Molecular Sciences. 21. PMID 32977401 DOI: 10.3390/ijms21196982 |
0.257 |
|
| 2009 |
Centonze D, Bari M, Di Michele B, Rossi S, Gasperi V, Pasini A, Battista N, Bernardi G, Curatolo P, Maccarrone M. Altered anandamide degradation in attention-deficit/hyperactivity disorder. Neurology. 72: 1526-7. PMID 19398708 DOI: 10.1212/Wnl.0B013E3181A2E8F6 |
0.257 |
|
| 2020 |
Campopiano R, Ferese R, Zampatti S, Giardina E, Biagioni F, Colonnese C, Centonze D, Storto M, Buttari F, Fraviga E, Broccoli V, Fanelli M, Fornai F, Gambardella S. A novel POLR3A genotype leads to leukodystrophy type-7 in two siblings with unusually late age of onset. Bmc Neurology. 20: 258. PMID 32600288 DOI: 10.1186/S12883-020-01835-9 |
0.256 |
|
| 2005 |
Centonze D, Siracusano A, Calabresi P, Bernardi G. Removing pathogenic memories: a neurobiology of psychotherapy. Molecular Neurobiology. 32: 123-32. PMID 16215277 DOI: 10.1385/Mn:32:2:123 |
0.255 |
|
| 2005 |
Brusa L, Versace V, Koch G, Bernardi G, Iani C, Stanzione P, Centonze D. Improvement of choreic movements by 1 Hz repetitive transcranial magnetic stimulation in Huntington's disease patients. Annals of Neurology. 58: 655-6. PMID 16178020 DOI: 10.1002/Ana.20613 |
0.255 |
|
| 2018 |
Becher J, Simula L, Volpe E, Procaccini C, La Rocca C, D'Acunzo P, Cianfanelli V, Strappazzon F, Caruana I, Nazio F, Weber G, Gigantino V, Botti G, Ciccosanti F, Borsellino G, ... ... Centonze D, et al. AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis. Developmental Cell. 47: 592-607.e6. PMID 30513302 DOI: 10.1016/J.Devcel.2018.11.010 |
0.255 |
|
| 2020 |
Stampanoni Bassi M, Buttari F, Simonelli I, Gilio L, Furlan R, Finardi A, Marfia GA, Visconti A, Paolillo A, Storto M, Gambardella S, Ferese R, Salvetti M, Uccelli A, Matarese G, ... Centonze D, et al. A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment. Genes. 11. PMID 33007809 DOI: 10.3390/genes11101152 |
0.252 |
|
| 2011 |
Oddi S, Dainese E, Fezza F, Lanuti M, Barcaroli D, De Laurenzi V, Centonze D, Maccarrone M. Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor. Journal of Neurochemistry. 116: 858-65. PMID 21214565 DOI: 10.1111/J.1471-4159.2010.07041.X |
0.252 |
|
| 2005 |
Centonze D, Siracusano A, Calabresi P, Bernardi G. Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms. Neuroscience. 130: 559-65. PMID 15590140 DOI: 10.1016/J.Neuroscience.2004.09.032 |
0.251 |
|
| 2023 |
Stampanoni Bassi M, Gilio L, Buttari F, Dolcetti E, Bruno A, Galifi G, Azzolini F, Borrelli A, Mandolesi G, Gentile A, De Vito F, Musella A, Simonelli I, Centonze D, Iezzi E. Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis. European Journal of Neurology. PMID 37754770 DOI: 10.1111/ene.16071 |
0.251 |
|
| 2019 |
Campopiano R, Ferese R, Buttari F, Femiano C, Centonze D, Fornai F, Biagioni F, Chiaravalloti MA, Magnani M, Giardina E, Ruzzo A, Gambardella S. A Novel Homozygous Variant in the Fork-Head-Associated Domain of Polynucleotide Kinase Phosphatase in a Patient Affected by Late-Onset Ataxia With Oculomotor Apraxia Type 4. Frontiers in Neurology. 10: 1331. PMID 32010037 DOI: 10.3389/Fneur.2019.01331 |
0.251 |
|
| 1999 |
Pisani A, Calabresi P, Centonze D, Marfia GA, Bernardi G. Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation. Journal of Neurophysiology. 81: 2508-16. PMID 10322086 DOI: 10.1152/Jn.1999.81.5.2508 |
0.249 |
|
| 2017 |
Di Giuliano F, Albanese M, Picchi E, Mori F, Buttari F, Marfia GA, Garaci F, Mercuri NB, Floris R, Centonze D, Marziali S. Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study. La Radiologia Medica. PMID 29116601 DOI: 10.1007/S11547-017-0829-4 |
0.249 |
|
| 2022 |
Gilio L, Fresegna D, Gentile A, Guadalupi L, Sanna K, De Vito F, Balletta S, Caioli S, Rizzo FR, Musella A, Iezzi E, Moscatelli A, Galifi G, Fantozzi R, Bellantonio P, ... ... Centonze D, et al. Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis. Neurobiology of Disease. 172: 105817. PMID 35835361 DOI: 10.1016/j.nbd.2022.105817 |
0.248 |
|
| 2024 |
Bianchi A, Matranga D, Patti F, Maniscalco L, Pilotto S, Di Filippo M, Zaffaroni M, Annovazzi P, Bertolotto A, Gasperini C, Quartuccio E, Centonze D, Fantozzi R, Gajofatto A, Gobbin F, et al. The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT). Journal of Neurology. PMID 38366072 DOI: 10.1007/s00415-024-12214-6 |
0.246 |
|
| 2022 |
Azzolini F, Gilio L, Pavone L, Iezzi E, Dolcetti E, Bruno A, Buttari F, Musella A, Mandolesi G, Guadalupi L, Furlan R, Finardi A, Micillo T, Carbone F, Matarese G, ... Centonze D, et al. Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis. Biomolecules. 12. PMID 35204724 DOI: 10.3390/biom12020222 |
0.245 |
|
| 2023 |
Errico F, Gilio L, Mancini A, Nuzzo T, Bassi MS, Bellingacci L, Buttari F, Dolcetti E, Bruno A, Galifi G, Furlan R, Finardi A, Di Maio A, Di Filippo M, Centonze D, et al. Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model. Journal of Neurochemistry. PMID 37332201 DOI: 10.1111/jnc.15884 |
0.245 |
|
| 1997 |
Calabresi P, Centonze D, Pisani A, Bernardi G. Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4509-16. PMID 9169511 |
0.243 |
|
| 2021 |
Rizzo FR, Guadalupi L, Sanna K, Vanni V, Fresegna D, De Vito F, Musella A, Caioli S, Balletta S, Bullitta S, Bruno A, Dolcetti E, Stampanoni Bassi M, Buttari F, Gilio L, ... ... Centonze D, et al. Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 98: 13-27. PMID 34391817 DOI: 10.1016/j.bbi.2021.08.212 |
0.242 |
|
| 2002 |
Pisani A, Bonsi P, Catania MV, Giuffrida R, Morari M, Marti M, Centonze D, Bernardi G, Kingston AE, Calabresi P. Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6176-85. PMID 12122076 |
0.242 |
|
| 2007 |
Sallustio F, Diomedi M, Centonze D, Stanzione P. Saving the ischemic penumbra: potential role for statins and phosphodiesterase inhibitors. Current Vascular Pharmacology. 5: 259-65. PMID 17979792 DOI: 10.2174/157016107782023424 |
0.242 |
|
| 2021 |
Reder AT, Centonze D, Naylor ML, Nagpal A, Rajbhandari R, Altincatal A, Kim M, Berdofe A, Radhakrishnan M, Jung E, Sandrock AW, Smirnakis K, Popescu C, de Moor C. COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. Cns Drugs. PMID 33743151 DOI: 10.1007/s40263-021-00804-1 |
0.241 |
|
| 2021 |
Mandolesi G, Rizzo FR, Balletta S, Stampanoni Bassi M, Gilio L, Guadalupi L, Nencini M, Moscatelli A, Ryan CP, Licursi V, Dolcetti E, Musella A, Gentile A, Fresegna D, Bullitta S, ... ... Centonze D, et al. The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis. Cells. 10. PMID 33562569 DOI: 10.3390/cells10020330 |
0.241 |
|
| 2014 |
Parodi B, Cordano C, Morando S, Bragoni A, Giunti D, Usai C, Centonze D, Rosbo NKD, Scannevin RH, Uccelli A. Monomethyl fumarate inhibits the NFkB pathway and pro-inflammatory cytokine expression in microglia through HCA2 signaling via the AMPK/Sirt axis Journal of Neuroimmunology. 275: 167-168. DOI: 10.1016/J.Jneuroim.2014.08.450 |
0.239 |
|
| 2023 |
Sciarretta F, Ceci V, Tiberi M, Zaccaria F, Li H, Zhou ZY, Sun Q, Konja D, Matteocci A, Bhusal A, Verri M, Fresegna D, Balletta S, Ninni A, Rosina M, ... ... Centonze D, et al. Lipocalin-2 promotes adipose-macrophage interactions to shape peripheral and central inflammatory responses in experimental autoimmune encephalomyelitis. Molecular Metabolism. 101783. PMID 37517520 DOI: 10.1016/j.molmet.2023.101783 |
0.239 |
|
| 2019 |
Liguori C, Ruffini R, Olivola E, Chiaravalloti A, Izzi F, Stefani A, Pierantozzi M, Mercuri NB, Modugno N, Centonze D, Schillaci O, Placidi F. Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study. Parkinsonism & Related Disorders. PMID 30930059 DOI: 10.1016/J.Parkreldis.2019.03.017 |
0.239 |
|
| 2023 |
Stampanoni Bassi M, Buttari F, Gilio L, Iezzi E, Galifi G, Carbone F, Micillo T, Dolcetti E, Azzolini F, Bruno A, Borrelli A, Mandolesi G, Rovella V, Storto M, Finardi A, ... ... Centonze D, et al. Osteopontin Is Associated with Multiple Sclerosis Relapses. Biomedicines. 11. PMID 36672686 DOI: 10.3390/biomedicines11010178 |
0.239 |
|
| 2022 |
Musella A, Centonze D. Electrophysiology of Endocannabinoid Signaling. Methods in Molecular Biology (Clifton, N.J.). 2576: 461-475. PMID 36152210 DOI: 10.1007/978-1-0716-2728-0_38 |
0.238 |
|
| 2015 |
Iannazzo S, Santoni L, Saleri C, Puma E, Vestri G, Giuliani L, Centonze D, Canonico PL. Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A752. PMID 26534213 DOI: 10.7175/Fe.V17I2S.1231 |
0.238 |
|
| 2000 |
Pisani A, Bonsi P, Centonze D, Giacomini P, Calabresi P. Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 839-46. PMID 10826535 DOI: 10.1097/00004647-200005000-00011 |
0.237 |
|
| 2018 |
Landi D, Centonze D, Marfia GA, Capra R, Scarpazza C. Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for apheresis: The seventh special issue." Journal of Clinical Apheresis. PMID 29430694 DOI: 10.1002/Jca.21616 |
0.237 |
|
| 2022 |
Bruno A, Dolcetti E, Centonze D. Theoretical and Therapeutic Implications of the Spasticity-Plus Syndrome Model in Multiple Sclerosis. Frontiers in Neurology. 12: 802918. PMID 35197915 DOI: 10.3389/fneur.2021.802918 |
0.237 |
|
| 2009 |
Ribolsi M, Koch G, Magni V, Di Lorenzo G, Rubino IA, Siracusano A, Centonze D. Abnormal brain lateralization and connectivity in schizophrenia. Reviews in the Neurosciences. 20: 61-70. PMID 19526734 DOI: 10.1515/Revneuro.2009.20.1.61 |
0.236 |
|
| 2001 |
Calabresi P, Saulle E, Marfia GA, Centonze D, Mulloy R, Picconi B, Hipskind RA, Conquet F, Bernardi G. Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum. Molecular Pharmacology. 60: 808-15. PMID 11562444 |
0.235 |
|
| 2021 |
Stampanoni Bassi M, Nuzzo T, Gilio L, Miroballo M, Casamassa A, Buttari F, Bellantonio P, Fantozzi R, Galifi G, Furlan R, Finardi A, De Rosa A, Di Maio A, Errico F, Centonze D, et al. Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis. Journal of Neurochemistry. PMID 34547109 DOI: 10.1111/jnc.15518 |
0.234 |
|
| 2018 |
Gambardella S, Ferese R, Scala S, Carboni S, Biagioni F, Emiliano G, Zampatti S, Modugno N, Fabbiano F, Fornai F, Centonze D, Ruggieri S. Mitochondrial Serine Protease HTRA2 p.G399S in a Female with Di George Syndrome and Parkinson's Disease. Parkinson's Disease. 2018: 5651435. PMID 30034773 DOI: 10.1155/2018/5651435 |
0.234 |
|
| 2021 |
Zackowski KM, Freeman J, Brichetto G, Centonze D, Dalgas U, DeLuca J, Ehde D, Elgott S, Fanning V, Feys P, Finlayson M, Gold SM, Inglese M, Marrie RA, Ploughman M, et al. Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458521999970. PMID 33720795 DOI: 10.1177/1352458521999970 |
0.233 |
|
| 2019 |
Comi G, Solari A, Leocani L, Centonze D, Otero-Romero S. Italian Consensus on treatment of spasticity in multiple sclerosis. European Journal of Neurology. PMID 31652369 DOI: 10.1111/ene.14110 |
0.233 |
|
| 2016 |
Annovazzi P, Capobianco M, Moiola L, Patti F, Frau J, Uccelli A, Centonze D, Perini P, Tortorella C, Prosperini L, Lus G, Fuiani A, Falcini M, Martinelli V, Comi G, et al. Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study. Journal of Neurology. PMID 27286847 DOI: 10.1007/S00415-016-8188-Y |
0.232 |
|
| 2017 |
Fianco G, Mongiardi MP, Levi A, De Luca T, Desideri M, Trisciuoglio D, Del Bufalo D, Cinà I, Di Benedetto A, Mottolese M, Gentile A, Centonze D, Ferrè F, Barilà D. Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma. Elife. 6. PMID 28594322 DOI: 10.7554/Elife.22593 |
0.232 |
|
| 2020 |
Romigi A, Ricciardo Rizzo G, Izzi F, Guerrisi M, Caccamo M, Testa F, Centonze D, Mercuri NB, Toschi N. Heart Rate Variability Parameters During Psychogenic Non-epileptic Seizures: Comparison Between Patients With Pure PNES and Comorbid Epilepsy. Frontiers in Neurology. 11: 713. PMID 32849194 DOI: 10.3389/Fneur.2020.00713 |
0.232 |
|
| 2015 |
Iannazzo S, Santoni L, Saleri C, Puma E, Vestri G, Giuliani L, Canonico PL, Centonze D. Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A758. PMID 26534246 DOI: 10.1016/J.Jval.2015.09.2472 |
0.232 |
|
| 2021 |
Belvisi D, Canevelli M, Baione V, Buscarinu MC, Pellicciari G, Fantozzi R, Creta A, Cecchi G, Cola G, Nicoletti CG, Cortese A, De Giglio L, Tartaglia M, Crisafulli SG, Bruno G, ... ... Centonze D, et al. Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520987541. PMID 33565913 DOI: 10.1177/1352458520987541 |
0.231 |
|
| 2022 |
Gilio L, Buttari F, Pavone L, Iezzi E, Galifi G, Dolcetti E, Azzolini F, Bruno A, Borrelli A, Storto M, Furlan R, Finardi A, Pekmezovic T, Drulovic J, Mandolesi G, ... ... Centonze D, et al. Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity. Biomedicines. 10. PMID 36140159 DOI: 10.3390/biomedicines10092058 |
0.226 |
|
| 2011 |
Centonze D. S10.3 Synaptic hyperexcitability mediated by interleukin-1β in multiple sclerosis Clinical Neurophysiology. 122: S28. DOI: 10.1016/S1388-2457(11)60088-6 |
0.225 |
|
| 2015 |
Rossi S, Studer V, Motta C, Centonze D. Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment. Journal of the Neurological Sciences. 350: 101-2. PMID 25676590 DOI: 10.1016/J.Jns.2015.01.023 |
0.224 |
|
| 2022 |
Dolcetti E, Bruno A, Azzolini F, Gilio L, Moscatelli A, De Vito F, Pavone L, Iezzi E, Gambardella S, Giardina E, Ferese R, Buttari F, Rizzo FR, Furlan R, Finardi A, ... ... Centonze D, et al. The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis. Genes. 13. PMID 35205376 DOI: 10.3390/genes13020332 |
0.224 |
|
| 2015 |
Monteleone F, Buccisano F, Boffa L, Buttari F, Di Veroli A, Borriello G, Rossi S, Centonze D. Reversible hyporegenerative anemia during natalizumab treatment. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 257-8. PMID 25186208 DOI: 10.1177/1352458514546516 |
0.223 |
|
| 2018 |
Gambardella S, Ferese R, Scala S, Carboni S, Biagioni F, Giardina E, Zampatti S, Modugno N, Fabbiano F, Fornai F, Centonze D, Ruggieri S. Erratum to "Mitochondrial Serine Protease HTRA2 p.G399S in a Female with Di George Syndrome and Parkinson's Disease". Parkinson's Disease. 2018: 5956437. PMID 30271531 DOI: 10.1155/2018/5956437 |
0.22 |
|
| 2017 |
Romigi A, Vitrani G, Centonze D, Pierantozzi M. Restless legs syndrome is highly prevalent in patients with postpolio syndrome. Sleep Medicine. PMID 29183652 DOI: 10.1016/J.Sleep.2017.09.020 |
0.22 |
|
| 2015 |
Rieckmann P, Boyko A, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Hommes O, Kesselring J, Kobelt G, Langdon D, Lelorier J, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, et al. Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group Multiple Sclerosis and Related Disorders. 4: 202-218. DOI: 10.1016/j.msard.2015.02.005 |
0.22 |
|
| 2021 |
Barbano L, Ziccardi L, Landi D, Nicoletti CG, Mataluni G, Falsini B, Centonze D, Marfia GA, Quaranta L, Parisi V. Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod. Advances in Therapy. PMID 34109558 DOI: 10.1007/s12325-021-01728-4 |
0.218 |
|
| 2002 |
Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, Bernardi G, Finazzi-Agrò A, Maccarrone M. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6900-7. PMID 12177188 |
0.216 |
|
| 2022 |
Petracca M, Ruggieri S, Barbuti E, Ianniello A, Fantozzi R, Maniscalco GT, Andreone V, Landi D, Marfia GA, Di Gregorio M, Iodice R, Sinisi L, Maida E, Missione R, Coppola C, ... ... Centonze D, et al. Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study. Neurology and Therapy. PMID 35653061 DOI: 10.1007/s40120-022-00364-6 |
0.216 |
|
| 2020 |
Ziccardi L, Barbano L, Boffa L, Albanese M, Nicoletti CG, Landi D, Grzybowski A, Falsini B, Marfia GA, Centonze D, Parisi V. Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis. Journal of Clinical Medicine. 9. PMID 33266435 DOI: 10.3390/jcm9113766 |
0.213 |
|
| 2017 |
Mandolesi G, De Vito F, Musella A, Gentile A, Bullitta S, Fresegna D, Sepman H, Di Sanza C, Haji N, Mori F, Buttari F, Perlas E, Ciotti MT, Hornstein E, Bozzoni I, ... ... Centonze D, et al. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 37: 546-561. PMID 28100738 DOI: 10.1523/JNEUROSCI.0851-16.2017 |
0.212 |
|
| 2008 |
Rossi S, Mataluni G, De Bartolo P, Prosperetti C, Foti F, De Chiara V, Musella A, Mandolesi L, Bernardi G, Centonze D, Petrosini L. Cerebellar control of cortico-striatal LTD. Restorative Neurology and Neuroscience. 26: 475-80. PMID 19096135 |
0.211 |
|
| 2003 |
Centonze D, Grande C, Saulle E, Martin AB, Gubellini P, Pavón N, Pisani A, Bernardi G, Moratalla R, Calabresi P. Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 8506-12. PMID 13679419 |
0.211 |
|
| 2011 |
Ribolsi M, Mori F, Monteleone F, Kusayanagi H, Centonze D. P18.6 TRPV1 channels regulate cortical excitability in humans Clinical Neurophysiology. 122: S139. DOI: 10.1016/S1388-2457(11)60496-3 |
0.21 |
|
| 2023 |
Azzolini F, Dolcetti E, Bruno A, Rovella V, Centonze D, Buttari F. Physical exercise and synaptic protection in human and pre-clinical models of multiple sclerosis. Neural Regeneration Research. 19: 1768-1771. PMID 38103243 DOI: 10.4103/1673-5374.389359 |
0.21 |
|
| 2005 |
Centonze D, Palmieri MG, Boffa L, Pierantozzi M, Stanzione P, Brusa L, Marciani M, Siracusano A, Bernardi G, Caramia M. Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study. Journal of Psychiatry & Neuroscience : Jpn. 30: 127-32. PMID 15798788 |
0.209 |
|
| 2023 |
Bruno A, Dolcetti E, Azzolini F, Buttari F, Gilio L, Iezzi E, Galifi G, Borrelli A, Furlan R, Finardi A, Carbone F, De Vito F, Musella A, Guadalupi L, Mandolesi G, ... ... Centonze D, et al. BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 71: 104528. PMID 36709576 DOI: 10.1016/j.msard.2023.104528 |
0.209 |
|
| 2012 |
Mori F, Kusayanagi H, Buttari F, Centini B, Monteleone F, Nicoletti CG, Bernardi G, Di Cantogno EV, Marciani MG, Centonze D. Early treatment with high-dose interferon beta-1a reverses cognitive and cortical plasticity deï¬cits in multiple sclerosis. Functional Neurology. 27: 163-8. PMID 23402677 |
0.208 |
|
| 2023 |
Amato MP, Bergamaschi R, Centonze D, Mirabella M, Marfia GA, Totaro R, Lus G, Brescia Morra V, Aguglia U, Comi C, Cavalla P, Zaffaroni M, Rovaris M, Grimaldi LM, Leoni S, et al. Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study. Journal of Neurology. PMID 37405689 DOI: 10.1007/s00415-023-11820-0 |
0.208 |
|
| 2021 |
Lucchini M, Prosperini L, Buscarinu MC, Centonze D, Conte A, Cortese A, Elia G, Fantozzi R, Ferraro E, Gasperini C, Ianniello A, Landi D, Marfia GA, Nociti V, Pozzilli C, et al. Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis. Journal of Neurology. PMID 33496861 DOI: 10.1007/s00415-021-10412-0 |
0.207 |
|
| 2020 |
Di Gennaro F, Marotta C, Storto M, D'Avanzo C, Foschini N, Maffei L, de Gaetano G, Centonze D, Iezzi E. SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation Patients Hospitalized at Neuroscience Hospital in Italy. Mediterranean Journal of Hematology and Infectious Diseases. 12: e2020063. PMID 32952974 DOI: 10.4084/Mjhid.2020.063 |
0.207 |
|
| 2021 |
Alborghetti M, Bellucci G, Gentile A, Calderoni C, Nicoletti F, Capra R, Salvetti M, Centonze D. Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint. Current Neuropharmacology. PMID 33784961 DOI: 10.2174/1570159X19666210330094017 |
0.205 |
|
| 2023 |
Centonze D, Amato MP, Brescia Morra V, Cocco E, De Stefano N, Gasperini C, Gallo P, Pozzilli C, Trojano M, Filippi M. Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4. Therapeutic Advances in Neurological Disorders. 16: 17562864231183221. PMID 37434878 DOI: 10.1177/17562864231183221 |
0.204 |
|
| 2020 |
Stampanoni Bassi M, Drulovic J, Pekmezovic T, Iezzi E, Sica F, Gilio L, Gentile A, Musella A, Mandolesi G, Furlan R, Finardi A, Marfia GA, Bellantonio P, Fantozzi R, Centonze D, et al. Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients. Therapeutic Advances in Neurological Disorders. 13: 1756286420970833. PMID 33343708 DOI: 10.1177/1756286420970833 |
0.201 |
|
| 1999 |
Calabresi P, Gubellini P, Centonze D, Sancesario G, Morello M, Giorgi M, Pisani A, Bernardi G. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2489-99. PMID 10087063 |
0.201 |
|
| 2017 |
Stampanoni Bassi M, Sancesario A, Morace R, Centonze D, Iezzi E. Cannabinoids in Parkinson's Disease. Cannabis and Cannabinoid Research. 2: 21-29. PMID 28861502 DOI: 10.1089/can.2017.0002 |
0.201 |
|
| 2019 |
Romigi A, Vitrani G, Caccamo M, Centonze D. Restless Legs Syndrome Related to Vortioxetine: A Case Report. Journal of Clinical Psychopharmacology. 39: 514-516. PMID 31433340 DOI: 10.1097/Jcp.0000000000001092 |
0.2 |
|
| 2022 |
Bruno A, Dolcetti E, Azzolini F, Moscatelli A, Gambardella S, Ferese R, Rizzo FR, Gilio L, Iezzi E, Galifi G, Borrelli A, Buttari F, Furlan R, Finardi A, De Vito F, ... ... Centonze D, et al. Interleukin 6 SNP Regulates Radiological and Inflammatory Activity in Multiple Sclerosis. Genes. 13. PMID 35627281 DOI: 10.3390/genes13050897 |
0.199 |
|
| 2023 |
De Vito F, Balletta S, Caioli S, Musella A, Guadalupi L, Vanni V, Fresegna D, Bassi MS, Gilio L, Sanna K, Gentile A, Bruno A, Dolcetti E, Buttari F, Pavone L, ... ... Centonze D, et al. MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis. Current Neuropharmacology. PMID 37021418 DOI: 10.2174/1570159X21666230404103914 |
0.199 |
|
| 2020 |
Bruno A, Dolcetti E, Rizzo FR, Fresegna D, Musella A, Gentile A, De Vito F, Caioli S, Guadalupi L, Bullitta S, Vanni V, Balletta S, Sanna K, Buttari F, Stampanoni Bassi M, ... Centonze D, et al. Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis. Frontiers in Cellular Neuroscience. 14: 647259. PMID 33574741 DOI: 10.3389/fncel.2020.647259 |
0.198 |
|
| 2020 |
Romigi A, D'Aniello A, Caccamo M, Vitrani G, Casciato S, Di Gioia B, Testa F, Centonze D, Di Gennaro G. Effects of eslicarbazepine as add-on therapy on sleep architecture in temporal lobe epilepsy: results from "Esleep" study. Sleep Medicine. 75: 287-293. PMID 32927378 DOI: 10.1016/J.Sleep.2020.06.033 |
0.195 |
|
| 2023 |
Dolcetti E, Bruno A, Azzolini F, Gilio L, Pavone L, Iezzi E, Galifi G, Gambardella S, Ferese R, Buttari F, De Vito F, Colantuono P, Furlan R, Finardi A, Musella A, ... ... Centonze D, et al. Genetic regulation of IL-8 influences disease presentation of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231155049. PMID 36803228 DOI: 10.1177/13524585231155049 |
0.195 |
|
| 2019 |
Romigi A, Maestri M, Nicoletta C, Vitrani G, Caccamo M, Siciliano G, Bonanni E, Centonze D, Sanduzzi A. Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2. Current Neurology and Neuroscience Reports. 19: 9. PMID 30739220 DOI: 10.1007/S11910-019-0924-0 |
0.195 |
|
| 2018 |
Romigi A, Franco V, Placidi F, Liguori C, Rastelli E, Vitrani G, Centonze D, Massa R. Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2. Current Neurology and Neuroscience Reports. 18: 102. PMID 30382420 DOI: 10.1007/S11910-018-0903-X |
0.194 |
|
| 2001 |
Centonze D, Pisani A, Bonsi P, Giacomini P, Bernardi G, Calabresi P. Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 1393-400. PMID 11160411 |
0.193 |
|
| 2021 |
De Vito F, Musella A, Fresegna D, Rizzo FR, Gentile A, Bassi MS, Gilio L, Buttari F, Procaccini C, Colamatteo A, Bullitta S, Guadalupi L, Caioli S, Vanni V, Balletta S, ... ... Centonze D, et al. MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis. Neuropathology and Applied Neurobiology. PMID 34490928 DOI: 10.1111/nan.12765 |
0.189 |
|
| 2022 |
Rieckmann P, Centonze D, Giovannoni G, Hua LH, Oreja-Guevara C, Selchen D, Sørensen PS, Vermersch P, Wiendl H, Salloukh H, Yamout B. Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary. Neurodegenerative Disease Management. PMID 36278394 DOI: 10.2217/nmt-2022-0027 |
0.188 |
|
| 2017 |
Studer V, Rocchi C, Motta C, Lauretti B, Perugini J, Brambilla L, Pareja-Gutierrez L, Camera G, Barbieri FR, Marfia GA, Centonze D, Rossi S. Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 3: 2055217317701317. PMID 28607756 DOI: 10.1177/2055217317701317 |
0.187 |
|
| 2017 |
Fianco G, Mongiardi MP, Levi A, Luca TD, Desideri M, Trisciuoglio D, Bufalo DD, Cinà I, Benedetto AD, Mottolese M, Gentile A, Centonze D, Ferrè F, Barilà D. Author response: Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma Elife. DOI: 10.7554/Elife.22593.033 |
0.186 |
|
| 2018 |
Comi G, Nicoletti F, Canonico PL, Centonze D. Letter to the Editor Regarding: A Comprehensive Review on Copemyl. Neurology and Therapy. PMID 30415356 DOI: 10.1007/S40120-018-0115-Y |
0.186 |
|
| 2022 |
Belvisi D, Canevelli M, Marfia GA, Ferraro E, Centonze D, Salvetti M, Conte A. Response to "Frailty in multiple sclerosis: A closer look at the deficit accumulation framework". Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211068150. PMID 35000469 DOI: 10.1177/13524585211068150 |
0.184 |
|
| 2022 |
Landi D, Grimaldi A, Bovis F, Ponzano M, Fantozzi R, Buttari F, Signoriello E, Lus G, Lucchini M, Mirabella M, Cellerino M, Inglese M, Cola G, Nicoletti CG, Mataluni G, ... Centonze D, et al. Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab. Neurology(R) Neuroimmunology & Neuroinflammation. 9. PMID 35273036 DOI: 10.1212/NXI.0000000000001157 |
0.184 |
|
| 2023 |
Rosenkranz SC, Ploughman M, Hvid LG, Zimmer P, Erickson K, Stellmann JP, Centonze D, Friese MA. The MoxFo initiative-Mechanisms of action: Biomarkers in multiple sclerosis exercise studies. Multiple Sclerosis (Houndmills, Basingstoke, England). 29: 1569-1577. PMID 37880953 DOI: 10.1177/13524585231204453 |
0.184 |
|
| 2019 |
Stampanoni Bassi M, Casciato S, Gilio L, Pavone L, Cafolla D, Sforza E, Alfonsi E, Simonelli I, Di Gennaro G, Centonze D, Iezzi E. Subclinical dysphagia in task-specific mouth tremor triggered by drinking. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 130: 1289-1291. PMID 31170653 DOI: 10.1016/J.Clinph.2019.05.009 |
0.182 |
|
| 2022 |
Marfia GA, Centonze D, Salvetti M, Ferraro E, Panetta V, Gasperini C, Mirabella M, Conte A. Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists. Frontiers in Neurology. 13: 898741. PMID 35911920 DOI: 10.3389/fneur.2022.898741 |
0.182 |
|
| 2019 |
Romigi A, Centonze D. Oral L-carnitine and pregnancy: real opportunity for narcoleptic women? Sleep Science (Sao Paulo, Brazil). 12: 124. PMID 31879547 DOI: 10.5935/1984-0063.20190060 |
0.18 |
|
| 2023 |
Bruno A, Buttari F, Dolcetti E, Azzolini F, Borrelli A, Lauritano G, Di Caprio V, Rizzo FR, Gilio L, Galifi G, Furlan R, Finardi A, Guadalupi L, Musella A, Mandolesi G, ... Centonze D, et al. Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231197928. PMID 37698019 DOI: 10.1177/13524585231197928 |
0.178 |
|
| 2020 |
Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia Gravis Associated With SARS-CoV-2 Infection. Annals of Internal Medicine. PMID 32776781 DOI: 10.7326/L20-0845 |
0.178 |
|
| 2020 |
Romigi A, Caccamo M, Vitrani G, Testa F, Nicoletta C, Sarno AC, Di Gioia B, Centonze D. A false alarm of narcolepsy: obstructive sleep apnea masquerading as narcolepsy and vice-versa: two further controversial cases. Sleep & Breathing = Schlaf & Atmung. PMID 32297143 DOI: 10.1007/S11325-020-02070-9 |
0.177 |
|
| 2021 |
Leuti A, Talamonti E, Gentile A, Tiberi M, Matteocci A, Fresegna D, Centonze D, Chiurchiù V. Macrophage Plasticity and Polarization Are Altered in the Experimental Model of Multiple Sclerosis. Biomolecules. 11. PMID 34200023 DOI: 10.3390/biom11060837 |
0.176 |
|
| 2021 |
Leuti A, Talamonti E, Gentile A, Tiberi M, Matteocci A, Fresegna D, Centonze D, Chiurchiù V. Macrophage Plasticity and Polarization Are Altered in the Experimental Model of Multiple Sclerosis. Biomolecules. 11. PMID 34200023 DOI: 10.3390/biom11060837 |
0.176 |
|
| 2024 |
Ruggieri S, Ianniello A, Copetti M, Altieri M, Centonze D, Cortese A, De Giglio L, Fantozzi R, Tortorella C, Gasperini C, Grimaldi LM, Landi D, Marfia GA, Mirabella M, Nistri R, et al. Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. e00338. PMID 38413275 DOI: 10.1016/j.neurot.2024.e00338 |
0.176 |
|
| 2022 |
Patti F, Chisari CG, Toscano S, Annovazzi P, Banfi P, Bergamaschi R, Clerici R, Conti MZ, Cortese A, Fantozzi R, Ferraro D, Fischetti M, Frigo M, Gatto M, Immovilli P, ... ... Centonze D, et al. Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study. Multiple Sclerosis and Related Disorders. 70: 104474. PMID 36584654 DOI: 10.1016/j.msard.2022.104474 |
0.176 |
|
| 2023 |
Oreja-Guevara C, Potra S, Bauer B, Centonze D, Giambastiani MP, Giovannoni G, Kesselring J, Langdon D, Morrow S, Nouvet-Gire J, Pontaga M, Rieckmann P, Schippling S, Alexandri N, Shanahan J, et al. Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care. Advances in Therapy. 40: 5131-5136. PMID 37812333 DOI: 10.1007/s12325-023-02638-3 |
0.176 |
|
| 2017 |
Al-Hashel JY, Ahmed SF, Alroughani R, Patten SB, Marrie RA, McKay KA, Evans C, Fisk JD, Fiest K, Tremlett H, Gattellari M, Worthington JM, Goumas C, Jalaludin B, Lee KR, ... ... Centonze D, et al. Contents Vol. 48, 2017 Neuroepidemiology. 48. DOI: 10.1159/000480039 |
0.176 |
|
| 2014 |
Ishii M, Katoh H, Takagi M, Kawamura M, Shimizu S, Guo Y, Miao Y, Ji X, Li M, Liu X, Allali G, Laidet M, Assal F, Chofflon M, Armand S, ... ... Centonze D, et al. Contents Vol. 71, 2014 European Neurology. 71. DOI: 10.1159/000362856 |
0.176 |
|
| 2023 |
Parisi V, Barbano L, Antonelli G, Nicoletti CG, Landi D, Mataluni G, Di Renzo A, Buttari F, Marfia GA, Centonze D, Ziccardi L. Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy. Journal of Clinical Medicine. 12. PMID 38002787 DOI: 10.3390/jcm12227175 |
0.172 |
|
| 2023 |
Tacchino A, Ponzio M, Confalonieri P, Leocani L, Inglese M, Centonze D, Cocco E, Gallo P, Paolicelli D, Rovaris M, Sabattini L, Tedeschi G, Prosperini L, Patti F, Bramanti P, et al. An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study. Jmir Serious Games. 11: e41371. PMID 37938895 DOI: 10.2196/41371 |
0.17 |
|
| 2022 |
Schmierer K, Wiendl H, Oreja-Guevara C, Centonze D, Chudecka A, Roy S, Boschert U. A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets. Neurodegenerative Disease Management. 13: 15-21. PMID 36545912 DOI: 10.2217/nmt-2022-0026 |
0.169 |
|
| 2022 |
Schmierer K, Wiendl H, Oreja-Guevara C, Centonze D, Chudecka A, Roy S, Boschert U. Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221099413. PMID 35672923 DOI: 10.1177/13524585221099413 |
0.162 |
|
| 2021 |
Landi D, Cola G, Mantero V, Balgera R, Moiola L, Nozzolillo A, Dattola V, Sinisi L, Fantozzi R, Di Lemme S, Centonze D, Mataluni G, Nicoletti CG, Marfia GA. Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection. Multiple Sclerosis and Related Disorders. 57: 103345. PMID 35158454 DOI: 10.1016/j.msard.2021.103345 |
0.157 |
|
| 2014 |
Laroni A, Brogi D, Morra VB, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL, Amato MP, Appendino L, Ardito B, Avolio C, ... ... Centonze D, et al. Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial Bmc Neurology. 14. PMID 24690227 DOI: 10.1186/1471-2377-14-65 |
0.155 |
|
| 2022 |
Oreja-Guevara C, Brownlee W, Celius EG, Centonze D, Giovannoni G, Hodgkinson S, Kleinschnitz C, Havrdova EK, Magyari M, Selchen D, Vermersch P, Wiendl H, Van Wijmeersch B, Salloukh H, Yamout B. Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence. Multiple Sclerosis and Related Disorders. 69: 104459. PMID 36565573 DOI: 10.1016/j.msard.2022.104459 |
0.154 |
|
| 2022 |
Creta A, Gilio L, Centonze D, Fantozzi R. Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis. Neurodegenerative Disease Management. 12: 195-201. PMID 35707977 DOI: 10.2217/nmt-2022-0014 |
0.154 |
|
| 2021 |
Avolio C, Centonze D. Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful. Neurology and Therapy. PMID 34718965 DOI: 10.1007/s40120-021-00291-y |
0.149 |
|
| 2008 |
Rocchetti MT, Centra M, Papale M, Bortone G, Palermo C, Centonze D, Ranieri E, Di Paolo S, Gesualdo L. Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Proteomics. 8: 206-16. PMID 18095357 DOI: 10.1002/pmic.200700492 |
0.149 |
|
| 2022 |
Filippi M, Amato MP, Centonze D, Gallo P, Gasperini C, Inglese M, Patti F, Pozzilli C, Preziosa P, Trojano M. Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion. Journal of Neurology. PMID 36138162 DOI: 10.1007/s00415-022-11385-4 |
0.148 |
|
| 2007 |
Garaci FG, Colangelo V, Ludovici A, Gaudiello F, Marziali S, Centonze D, Boffa L, Simonetti G, Floris R. A diffusion longitudinal MR imaging study in normal-appearing white matter in untreated relapsing-remitting multiple sclerosis. Ajnr. American Journal of Neuroradiology. 28: 475-8. PMID 17353315 |
0.148 |
|
| 2009 |
Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, Vecchio R, Maimone D, ... ... Centonze D, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: Baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study Multiple Sclerosis. 15: 779-788. PMID 19542262 DOI: 10.1177/1352458509105544 |
0.146 |
|
| 2003 |
Pisani A, Bonsi P, Centonze D, Martorana A, Fusco F, Sancesario G, De Persis C, Bernardi G, Calabresi P. Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 5272-82. PMID 12832552 |
0.144 |
|
| 2023 |
Di Maio A, Nuzzo T, Gilio L, Serra M, Buttari F, Errico F, De Rosa A, Bassi MS, Morelli M, Sasabe J, Sulzer D, Carta M, Centonze D, Usiello A. Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients. Neurobiology of Disease. 106203. PMID 37336364 DOI: 10.1016/j.nbd.2023.106203 |
0.144 |
|
| 2021 |
Procaccini C, Garavelli S, Carbone F, Di Silvestre D, La Rocca C, Greco D, Colamatteo A, Lepore MT, Russo C, De Rosa G, Faicchia D, Prattichizzo F, Grossi S, Campomenosi P, Buttari F, ... ... Centonze D, et al. Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential. Immunity. PMID 34004141 DOI: 10.1016/j.immuni.2021.04.014 |
0.144 |
|
| 2023 |
Carbone L, Landi D, Di Girolamo R, Anserini P, Centonze D, Marfia GA, Alviggi C. Optimizing the "Time to pregnancy" in women with multiple sclerosis: the OPTIMUS Delphi survey. Frontiers in Neurology. 14: 1255496. PMID 37869135 DOI: 10.3389/fneur.2023.1255496 |
0.141 |
|
| 2001 |
Centonze D, Saulle E, Bernardi G, Calabresi P. Receptor and post-receptor mechanisms of ischemic long-term potentiation in the striatum. Functional Neurology. 16: 149-52. PMID 11996510 |
0.14 |
|
| 2015 |
Cencioni MT, Santini S, Ruocco G, Borsellino G, De Bardi M, Grasso MG, Ruggieri S, Gasperini C, Centonze D, Barilá D, Battistini L, Volpe E. FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients. Cell Death & Disease. 6: e1785. PMID 26068793 DOI: 10.1038/cddis.2015.164 |
0.138 |
|
| Hide low-probability matches. |